Viral pneumonia

J10_VIRALPNEUMO

viral pneumonia: Inflammation of the lung parenchyma that is caused by a viral infection.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J12\|J171\|J100\|J110\|B012\|B068\|B250 Hospital discharge: ICD-9 — 480\|4870A Hospital discharge: ICD-8 — 48099\|47101\|47109 Cause of death: ICD-10 — J12\|J171\|J100\|J110\|B012\|B068\|B250 Cause of death: ICD-9 — 480\|4870A Cause of death: ICD-8 — 48099\|47101\|47109 2 out of 7 registries used, show all original rules.	5446
4. Check minimum number of events None	5446
5. Include endpoints None	5446
6. Filter based on genotype QC (FinnGen only)	5446

Control definitions (FinnGen only)

Control exclude: J10_INFLUPNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	J10_VIRALPNEUMO
CONTROL_EXCLUDE	J10_INFLUPNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J12\|J171\|J100\|J110\|B012\|B068\|B250
HD_ICD_9	480\|4870A
HD_ICD_8	48099\|47101\|47109
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J12\|J171\|J100\|J110\|B012\|B068\|B250
COD_ICD_9	480\|4870A
COD_ICD_8	48099\|47101\|47109
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Viral pneumonia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	47722	21518	25878
Only index persons	39771	17942	21829
Unadjusted period prevalence (%)
Whole population	0.67	0.62	0.72
Only index persons	0.75	0.66	0.83
Median age at first event (years)
Whole population	49.11	56.07	43.15
Only index persons	46.32	54.15	39.88

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5446	2555	2891
Unadjusted period prevalence (%)	1.09	0.87	1.27
Median age at first event (years)	59.31	55.87	62.36

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4709: Matched controls
47089

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

4.3

323.3

1449

4390

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

1134.6

323.0

681

J12.8

ICD-10 Finland

Other viral pneumonia

4272.5

323.0

1046

J18.9

ICD-10 Finland

Pneumonia, unspecified

42.8

323.0

2269

1002

48099

ICD-8 Finland

Viral pneumonia

+∞

323.0

309

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

6184.9

323.0

1374

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

323.0

417

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

468.5

323.0

429

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

112.5

323.0

803

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

92.3

323.0

366

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.2

291.6

2439

11971

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.5

269.3

1110

3027

4809X

ICD-9 Finland

Viral pneumonia, unspecified

+∞

247.0

235

C03CA01

ATC

furosemide; systemic

3.2

232.9

1623

6722

H02AB06

ATC

prednisolone; systemic

2.7

223.4

2424

13236

J01MA14

ATC

moxifloxacin; systemic

6.2

207.4

606

1098

R03AC02

ATC

salbutamol; inhalant

2.5

190.3

2658

16145

J45.9

ICD-10 Finland

Asthma, unspecified

3.4

190.2

1075

3728

R50.9

ICD-10 Finland

Fever, unspecified

3.8

188.5

930

2887

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.5

175.9

691

1733

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.1

172.1

1141

4403

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

11.1

170.8

338

327

J01MA12

ATC

levofloxacin; systemic

3.2

167.5

1034

3786

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.2

165.8

1025

3752

R06.0

ICD-10 Finland

Dyspnoea

2.8

164.5

1337

5868

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

109.4

164.3

179

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.6

158.9

602

1447

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.4

158.0

896

3067

I50.9

ICD-10 Finland

Heart failure, unspecified

3.6

154.3

786

2469

R03BB04

ATC

tiotropium bromide; inhalant

4.4

153.0

608

1530

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

150.6

1179

5012

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.8

146.3

390

615

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

+∞

145.5

139

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.3

136.8

797

2757

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.1

132.0

561

1494

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.6

128.5

486

1155

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.1

126.4

2434

15895

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.4

125.4

494

1221

XF400

NOMESCO Finland

ECG with 12 standard connections

2.8

122.3

942

3898

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

6.1

113.8

330

578

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.0

111.3

2103

13369

R4110

NOMESCO Finland

Physiotherapy

2.3

110.0

1329

6951

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.5

101.7

520

1605

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.3

101.0

404

1006

R81

ICPC

Pneumonia

8.9

99.2

219

256

J45.1

ICD-10 Finland

Nonallergic asthma

3.9

99.0

438

1196

A28

ICPC

Limited function/disability NOS

2.7

99.0

769

3161

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.4

96.0

519

1669

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

95.5

843

3720

127

Kela drug reimbursment

Transplant complication

12.1

95.2

178

152

J46

ICD-10 Finland

Status asthmaticus

8.0

95.2

224

291

J01CA04

ATC

amoxicillin; systemic

2.1

95.0

3716

30309

A02BC02

ATC

pantoprazole; systemic

1.9

94.6

2829

20842

I50.0

ICD-10 Finland

Congestive heart failure

4.0

94.6

410

1098

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

94.4

730

2984

J01FA06

ATC

roxithromycin; oral

2.0

93.5

1802

11307

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.9

92.8

653

2516

AA1AD

NOMESCO Finland

CT of head and brain

2.2

92.2

1130

5865

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

91.8

1380

7830

R02

ICPC

Shortness of breath/dyspnoea

2.8

91.6

648

2506

TGC00

NOMESCO Finland

Bronchial lavation

8.5

88.0

199

242

ZXD05

NOMESCO Finland

Urgent procedure

2.0

85.7

1468

8728

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

4.6

84.5

315

729

L04AA06

ATC

mycophenolic acid; systemic

9.9

83.7

173

180

R53

ICD-10 Finland

Malaise and fatigue

2.2

83.1

991

5049

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

8.0

82.6

194

251

J01DB01

ATC

cefalexin; oral

2.0

81.0

3692

30608

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.7

80.2

372

1053

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

79.4

612

2479

J96.1

ICD-10 Finland

Chronic respiratory failure

11.5

79.0

151

135

ZX120

NOMESCO Finland

Intravenous

2.9

78.0

514

1887

R03BA05

ATC

fluticasone; inhalant

2.3

78.0

877

4333

J01AA02

ATC

doxycycline; systemic

1.8

77.6

3358

27055

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

77.3

533

2015

N02BE01

ATC

paracetamol; systemic, rectal

2.0

77.0

3801

32033

TK800

NOMESCO Finland

Hemodialysis

7.4

77.0

190

265

WX892

NOMESCO Finland

Monitored bed care

3.3

76.6

429

1406

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

76.4

845

4135

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.6

75.6

280

643

A41.9

ICD-10 Finland

Sepsis, unspecified

5.3

75.2

240

469

N02AX02

ATC

tramadol; systemic, rectal

1.8

74.8

1848

12373

R03DC03

ATC

montelukast; oral

2.3

74.4

755

3538

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

5.3

74.3

237

463

A06AD11

ATC

lactulose; oral

2.4

74.0

694

3123

R03BA02

ATC

budesonide; inhalant

2.2

74.0

844

4185

R03AK07

ATC

formoterol and budesonide; inhalant

2.2

73.6

873

4408

R03DA04

ATC

theophylline; systemic, rectal

4.0

72.9

308

802

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.0

72.9

209

359

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

72.8

823

4061

H02AB04

ATC

methylprednisolone; systemic

2.4

72.5

702

3209

J01FF01

ATC

clindamycin; systemic

2.0

71.6

1214

7093

C07AB07

ATC

bisoprolol; oral

1.8

71.5

1988

13766

A46

ICD-10 Finland

Erysipelas

2.4

71.2

674

3046

N03AX16

ATC

pregabalin; oral

2.0

70.9

1039

5729

Z3231

NOMESCO Finland

Registered nurse

1.9

70.5

1284

7699

GD1AD

NOMESCO Finland

Thorax CT examination

4.7

70.2

254

569

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.6

70.0

338

987

B01AA03

ATC

warfarin; systemic

2.1

69.0

907

4777

4808X

ICD-9 Finland

Viral pneumonia, Pneumonia due to other virus not elsewhere classified

+∞

68.9

A03

ICPC

Fever

2.2

68.5

788

3906

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.1

67.9

226

463

48609

ICD-8 Finland

Pneumonia, unspecified

+∞

67.9

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

67.6

1217

7248

J96.0

ICD-10 Finland

Acute respiratory failure

14.1

67.4

117

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.6

67.1

180

283

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

66.3

1243

7497

J01MA02

ATC

ciprofloxacin; systemic

1.8

65.5

1673

11188

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

172.4

65.1

Z3226

NOMESCO Finland

Physiotherapist

2.1

64.8

854

4484

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

64.3

1578

10404

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

64.1

1305

8087

J45

ICD-10 Finland

Asthma

2.7

64.1

482

1911

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

15.5

63.5

106

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.9

63.2

275

734

Z2446

NOMESCO Finland

Social worker

3.1

63.2

376

1281

ZXE00

NOMESCO Finland

One hour or less

1.7

61.8

1759

12097

Z2221

NOMESCO Finland

Medical doctor

1.8

61.6

1259

7791

C08CA01

ATC

amlodipine; oral

1.8

61.2

1490

9760

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

56.2

60.8

47109

ICD-8 Finland

Influenza with pneumonia, Unspecified

+∞

60.5

H02AB07

ATC

prednisone; oral

2.3

60.4

639

3032

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

60.1

941

5283

N02AA05

ATC

oxycodone; systemic

2.3

59.3

625

2959

XW000

NOMESCO Finland

Bone marrow biopsy

3.9

59.3

258

688

M04AA01

ATC

allopurinol; systemic

2.3

59.3

600

2785

B01AB05

ATC

enoxaparin; parenteral

1.8

58.7

1246

7786

WX730

NOMESCO Finland

Conventional respirator

8.1

58.6

136

173

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

18.0

58.5

L28

ICPC

Limited function/disability (L)

2.2

58.0

702

3538

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

57.9

626

2997

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.8

56.3

400

1527

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.7

56.2

169

308

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

12.5

55.9

102

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.3

55.9

218

526

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

55.6

907

5149

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.6

55.3

452

1874

J15.8

ICD-10 Finland

Other bacterial pneumonia

78.6

55.1

R03AC03

ATC

terbutaline; inhalant

2.2

54.0

643

3211

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

53.7

2326

17739

Z49.1

ICD-10 Finland

Extracorporeal dialysis

8.3

53.7

122

150

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.0

52.9

178

369

B03XA02

ATC

darbepoetin alfa; parenteral

6.9

52.6

135

200

J12.2

ICD-10 Finland

Parainfluenza virus pneumonia

+∞

52.2

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

51.8

1637

11444

R03AC12

ATC

salmeterol; inhalant

3.8

51.7

232

635

5AH02

NOMESCO Finland

+∞

51.1

N18.8

ICD-10 Finland

Other chronic renal failure

4.7

50.1

178

391

J01FA10

ATC

azithromycin; systemic

1.6

50.0

2445

19086

WX872

NOMESCO Finland

Intensive care

3.3

49.7

263

822

R05

ICPC

Cough

1.8

49.5

942

5625

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

49.3

931

5544

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

49.2

491

2254

XF600

NOMESCO Finland

Bloodpressure measurement

2.8

49.1

339

1268

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

9.3

49.1

104

114

N05BA04

ATC

oxazepam; oral

1.8

49.0

1036

6403

Z94.0

ICD-10 Finland

Kidney transplant status

9.1

48.8

105

118

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.8

48.8

333

1238

SPAT1255

SPAT

Intravenous administration of medicine

2.9

48.6

319

1155

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.0

48.4

291

997

WW200

NOMESCO Finland

Immunization

4.4

48.3

183

429

ZX108

NOMESCO Finland

Inhalation

15.3

48.0

WX882

NOMESCO Finland

High dependency care

4.5

48.0

178

409

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.3

47.9

260

828

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

47.8

1476

10193

R60.0

ICD-10 Finland

Localized oedema

2.3

47.6

484

2238

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.0

47.4

291

1011

S97

ICPC

Chronic ulcer skin

3.2

47.3

268

879

J45.8

ICD-10 Finland

Mixed asthma

4.4

47.3

178

415

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.6

47.3

384

1581

A10AE04

ATC

insulin glargine; parenteral

2.4

47.1

449

2014

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

46.8

1108

7082

A11CC03

ATC

alfacalcidol; systemic

5.1

46.7

152

304

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

46.5

313

1154

WX110

NOMESCO Finland

Local anesthesy

1.6

46.5

2983

24677

XG410

NOMESCO Finland

Flow-volume spirometry

3.5

46.4

226

662

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.4

46.4

145

277

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.6

46.0

166

371

Z29.8

ICD-10 Finland

Other specified prophylactic measures

4.7

45.8

161

350

H02AB09

ATC

hydrocortisone; systemic

4.9

45.8

156

328

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

6.9

45.4

116

171

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.3

45.3

174

414

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.3

45.1

245

781

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

7.4

45.0

110

152

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.4

45.0

412

1808

L03AA02

ATC

filgrastim; parenteral

4.7

44.9

157

340

JN4BD

NOMESCO Finland

Extensive body CT

2.3

44.7

470

2207

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

44.6

1897

14162

SPAT1254

SPAT

Administration of medicine

2.0

44.0

676

3722

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

43.9

396

1724

WX722

NOMESCO Finland

PEEP

3.2

43.9

242

780

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

7.0

43.8

111

162

C03DA01

ATC

spironolactone; oral

2.3

43.7

454

2118

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

43.7

581

3023

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

19.7

43.5

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

10.9

43.4

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

43.2

930

5748

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

43.2

879

5338

48509

ICD-8 Finland

Bronchopneumonia, unspecified

+∞

42.8

4801A

ICD-9 Finland

Viral pneumonia, Pneumonia due to respiratory syncytial virus

+∞

42.8

N05AH04

ATC

quetiapine; oral

1.9

42.8

699

3937

J01DA01

ATC

[U] cefalexin; systemic

1.5

42.7

2631

21336

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

42.5

811

4818

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.9

42.4

279

1012

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

10.7

42.3

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

42.2

598

3188

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

42.0

438

2047

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.3

41.9

132

255

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

+∞

41.7

WW500

NOMESCO Finland

Blood transfusion

3.5

41.3

204

605

N06AX11

ATC

mirtazapine; oral

1.6

41.0

1280

8787

L04AD01

ATC

ciclosporin; systemic

5.3

41.0

129

249

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

40.6

349

1478

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

40.6

377

1662

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.7

40.6

302

1182

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.7

40.6

183

504

N18.0

ICD-10 Finland

End-stage renal disease

7.9

40.4

121

WX726

NOMESCO Finland

High-flow oxygen therapy

206.7

39.9

N03AX12

ATC

gabapentin; oral

1.9

39.9

625

3459

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

39.8

329

1366

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.2

39.8

157

384

JN4AD

NOMESCO Finland

Body CT examination

2.5

39.7

328

1359

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

10.9

39.7

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

39.7

305

1214

WX002

NOMESCO Finland

Sedation and analgesia

1.8

39.7

820

4990

A12AA04

ATC

calcium carbonate; oral

5.9

39.4

113

195

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.8

39.3

267

989

R03BA01

ATC

beclometasone; inhalant

2.0

39.2

575

3100

WX725

NOMESCO Finland

Noninvasive ventilation

3.1

39.2

230

773

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.3

39.1

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.6

38.9

116

210

SPAT1263

SPAT

Sampling

1.5

38.8

1785

13438

N30.0

ICD-10 Finland

Acute cystitis

2.0

38.8

548

2910

ZXA00

NOMESCO Finland

Right side

1.7

38.8

1088

7240

A04

ICPC

Weakness/tiredness general

2.0

38.6

559

3001

J20

ICD-10 Finland

Acute bronchitis

2.2

38.2

403

1891

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

38.2

1696

12650

SPAT1262

SPAT

Handing over of treatment supplies

1.8

38.0

755

4526

R06.2

ICD-10 Finland

Wheezing

3.1

38.0

218

722

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

38.0

990

6447

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

37.9

1359

9629

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

37.8

456

2269

A02BC01

ATC

omeprazole; systemic

1.6

37.8

1105

7427

N05CF01

ATC

zopiclone; oral

1.6

37.6

1260

8773

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

37.6

876

5523

R03AC13

ATC

formoterol; inhalant

3.0

37.4

228

787

C90.0

ICD-10 Finland

Multiple myeloma

8.3

37.3

103

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.9

37.2

107

186

R11

ICD-10 Finland

Nausea and vomiting

2.3

37.2

360

1621

L04AX01

ATC

azathioprine; systemic

3.1

37.1

212

700

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

5.3

37.1

117

227

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

5.6

37.0

111

203

J47

ICD-10 Finland

Bronchiectasis

7.3

36.9

125

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.3

36.8

360

1626

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

49.3

36.6

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

36.5

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

36.4

232

825

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

5.5

36.4

110

203

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

15.2

36.1

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.9

35.9

232

830

R51.80

ICD-10 Finland

Headache

1.9

35.9

616

3510

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

35.9

1505

11036

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

35.3

1083

7349

M10.9

ICD-10 Finland

Gout, unspecified

2.5

35.2

288

1188

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

10.4

35.0

XG466

NOMESCO Finland

Sleep oxymetry

3.6

34.8

164

469

G47.3

ICD-10 Finland

Sleep apnoea

1.7

34.8

845

5375

M79.6

ICD-10 Finland

Pain in limb

1.5

34.6

1390

10070

J01FA09

ATC

clarithromycin; systemic

1.6

34.6

1229

8649

R03AK08

ATC

formoterol and beclometasone; inhalant

3.4

34.4

175

531

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.2

34.3

188

603

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.8

34.2

232

858

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

34.1

321

1423

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

34.0

262

1045

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

18.8

33.9

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

18.8

33.9

N19

ICD-10 Finland

Unspecified kidney failure

3.4

33.9

168

500

N05CD07

ATC

temazepam; oral

2.0

33.8

504

2724

R96

ICPC

Asthma

2.2

33.6

349

1622

R95

ICPC

Chron obstructive pulmonary disease

4.4

33.3

124

287

A07AA02

ATC

nystatin; oral

2.5

32.8

263

1072

N05BA01

ATC

diazepam; systemic, rectal

1.9

32.7

533

2979

Z71.8

ICD-10 Finland

Other specified counselling

1.6

32.6

963

6454

J43.9

ICD-10 Finland

Emphysema, unspecified

6.7

32.5

127

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

32.5

203

712

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

32.3

1147

8048

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

12.5

32.2

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

8.8

32.0

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

32.0

480

2603

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.3

31.9

123

295

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

31.9

840

5455

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

13.2

31.8

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

31.7

1040

7153

R03BB01

ATC

ipratropium bromide; inhalant

3.2

31.7

170

538

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

31.7

598

3511

R06AE07

ATC

cetirizine; oral

1.5

31.7

1712

13177

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.6

31.5

242

962

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.3

31.4

162

498

E66.8

ICD-10 Finland

Other obesity

2.7

31.4

220

831

N03AG01

ATC

valproic acid; systemic, rectal

2.5

31.4

257

1059

E0000UV

ATC

1.5

31.2

1571

11903

R83

ICPC

Respiratory infection other

1.6

31.1

1005

6880

B01AF02

ATC

apixaban; oral

2.1

31.0

386

1944

N03AE01

ATC

clonazepam; systemic

2.6

30.8

244

986

L04AA01

ATC

[U] ciclosporin; systemic

5.5

30.7

173

137

Kela drug reimbursment

Uraemia requiring dialysis

8.6

30.6

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

4.9

30.5

103

216

207

Kela drug reimbursment

Chronic arrhythmias

1.8

30.5

559

3247

UJF32

NOMESCO Finland

Coloscopy

1.6

30.5

972

6626

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.0

30.4

181

615

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.6

30.2

235

943

C01DA14

ATC

isosorbide mononitrate; oral

1.8

30.0

604

3618

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

29.9

415

2181

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.5

29.9

109

248

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

29.7

664

4104

TK810

NOMESCO Finland

Hemofiltration

10.5

29.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

6.6

29.6

118

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

8.9

29.3

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.8

29.2

195

716

V03AE02

ATC

sevelamer; oral

12.9

28.8

I50.1

ICD-10 Finland

Left ventricular failure

2.8

28.8

197

734

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

28.7

324

1561

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

28.6

499

2851

V03AE01

ATC

polystyrene sulfonate; oral

6.0

28.5

136

R03AK11

ATC

formoterol and fluticasone; inhalant

3.7

28.3

128

355

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.8

28.3

124

335

ZX100

NOMESCO Finland

Oral

4.9

28.2

191

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.5

28.1

154

N05AA02

ATC

levomepromazine; systemic

2.8

27.8

186

683

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.3

27.8

274

1243

R05FB02

ATC

cough suppressants and expectorants

1.5

27.7

1413

10669

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.9

27.7

133

UKC02

NOMESCO Finland

Cystoscopy

1.7

27.6

635

3955

X58

ICD-10 Finland

Exposure to other specified factors

1.8

27.4

559

3354

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.1

27.0

174

153

Kela drug reimbursment

Lenalidomid

12.7

27.0

I50

ICD-10 Finland

Heart failure

3.5

27.0

132

390

B03XA01

ATC

erythropoietin; parenteral

7.8

26.9

ZY010

NOMESCO Finland

Hospital outpatient

2.5

26.8

220

909

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

26.8

634

3978

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.4

26.8

155

R04.2

ICD-10 Finland

Haemoptysis

3.1

26.7

149

486

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.7

26.7

121

337

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

26.6

271

1247

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

26.4

191

736

L04AX04

ATC

lenalidomide; oral

13.3

26.4

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

8.2

26.3

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

26.0

377

2013

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.3

26.0

135

418

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

25.9

266

1228

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

25.9

372

1981

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

25.9

423

2358

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.7

25.6

189

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.8

25.6

170

622

C08CA02

ATC

felodipine; oral

2.0

25.6

366

1944

C09AA05

ATC

ramipril; oral

1.5

25.5

922

6442

J05AB11

ATC

valaciclovir; oral

1.8

25.4

497

2941

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

25.4

296

1448

205

Kela drug reimbursment

Chronic hypertension

1.5

25.3

1054

7600

J02AC01

ATC

fluconazole; systemic

1.4

25.2

1370

10431

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

25.1

268

1259

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

25.1

529

3202

J12.0

ICD-10 Finland

Adenoviral pneumonia

+∞

25.0

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

24.9

731

4850

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

24.9

310

1559

A10AE05

ATC

insulin detemir; parenteral

2.3

24.8

242

1092

J01FA01

ATC

erythromycin; systemic

1.7

24.8

555

3421

A41.8

ICD-10 Finland

Other specified sepsis

4.9

24.7

170

B01AC04

ATC

clopidogrel; oral

1.7

24.7

582

3639

B05DA

ATC

Isotonic solutions

8.8

24.7

R05

ICD-10 Finland

Cough

1.6

24.7

736

4907

R74

ICPC

Upper respiratory infection acute

1.5

24.6

1097

8016

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.4

24.6

223

970

R33

ICD-10 Finland

Retention of urine

2.0

24.4

317

1619

M05BA04

ATC

alendronic acid; oral

2.1

24.4

296

1474

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

24.2

305

1539

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

24.2

212

908

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

24.0

1106

8133

C01AA05

ATC

digoxin; systemic

2.1

24.0

301

1516

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.7

24.0

168

636

H3603, E103

ICD-10 Finland

5.9

23.9

114

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

20.7

23.8

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

23.7

275

1342

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

10.1

23.7

J02AC03

ATC

voriconazole; systemic

41.6

23.6

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

23.5

199

836

S18

ICPC

Laceration/cut

1.4

23.5

1591

12584

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

23.5

834

5791

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.9

23.3

114

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

23.3

368

2024

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

23.3

1065

7812

AN1

Coronary angiography

1.8

23.3

442

2588

L17

ICPC

Foot/toe symptom/complaint

1.5

23.3

937

6691

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.9

23.2

146

517

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

23.2

1225

9243

N05AH02

ATC

clozapine; systemic

3.8

23.2

263

B01AB10

ATC

tinzaparin; parenteral

2.1

23.1

259

1246

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

23.1

771

5274

49300

ICD-8 Finland

Asthma, bronchiale

3.4

23.0

115

347

RS220

NOMESCO Finland

5.1

22.9

145

J05AB01

ATC

aciclovir; systemic

1.5

22.8

767

5251

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

22.8

407

2336

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

22.7

264

1290

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

22.7

352

1924

C09AA02

ATC

enalapril; systemic

1.6

22.7

743

5057

T90

ICPC

Diabetes non-insulin dependent

1.5

22.7

829

5791

WX704

NOMESCO Finland

Intubation

2.1

22.5

277

1383

A02BC05

ATC

esomeprazole; systemic

1.4

22.4

1488

11698

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

22.4

372

2081

N05AH03

ATC

olanzapine; systemic

2.2

22.1

243

1159

N06AB04

ATC

citalopram; systemic

1.5

22.1

773

5340

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

22.1

601

3903

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.0

22.1

225

ZXA05

NOMESCO Finland

Left side

1.5

22.0

946

6838

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

22.0

460

2775

4800A

ICD-9 Finland

Viral pneumonia, Pneumonia due to adenovirus

+∞

21.9

B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

21.9

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.2

21.9

115

361

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.1

21.8

120

389

A04AA01

ATC

ondansetron; systemic, rectal

2.2

21.6

239

1142

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.8

21.6

249

J01EA01

ATC

trimethoprim; systemic

1.5

21.5

891

6387

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

21.4

997

7322

Z94.2

ICD-10 Finland

Lung transplant status

43.5

21.4

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

21.3

404

2366

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

21.2

340

1880

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

21.2

401

2342

A10BA02

ATC

metformin; oral

1.5

21.2

1010

7449

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

7.9

21.2

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.5

21.1

165

665

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

21.0

396

2309

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

21.0

1035

7679

B05DB

ATC

Hypertonic solutions

9.1

21.0

ZXA10

NOMESCO Finland

Bilateral

1.5

21.0

704

4812

Z29.0

ICD-10 Finland

Isolation

12.0

21.0

R01AD09

ATC

mometasone; nasal

1.4

21.0

1688

13676

R03BA08

ATC

ciclesonide; inhalant

1.9

21.0

301

1600

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

20.9

311

1675

XF404

NOMESCO Finland

Ambulatory ECG

1.8

20.9

365

2077

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.2

20.7

213

985

P01AB01

ATC

metronidazole; oral, rectal

1.4

20.7

1409

11092

A01AB09

ATC

miconazole; local oral

1.9

20.7

322

1762

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

8.1

20.6

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

20.6

234

1133

J10.8

ICD-10 Finland

Influenza with other manifestations, seasonal influenza virus identified

110.5

20.6

N06AX16

ATC

venlafaxine; oral

1.7

20.5

488

3053

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

20.5

321

1760

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

20.5

164

671

Z49.2

ICD-10 Finland

Other dialysis

7.0

20.3

N03AX09

ATC

lamotrigine; oral

2.4

20.3

182

790

J80

ICD-10 Finland

Adult respiratory distress syndrome

14.3

20.3

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.5

20.3

157

631

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.4

20.2

290

J01DA06

ATC

[U] cefuroxime; systemic

1.6

20.1

526

3374

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

20.1

312

1705

A10BH01

ATC

sitagliptin; oral

1.8

20.1

353

2015

R03CC02

ATC

salbutamol; systemic

2.0

20.0

261

1336

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

5.1

19.9

125

R4120

NOMESCO Finland

Occupational therapy

2.1

19.9

240

1189

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.8

19.9

134

495

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

19.9

207

964

SPAT1060

SPAT

Administration of oxygen

12.6

19.8

A02BC03

ATC

lansoprazole; oral

1.4

19.8

1048

7873

4870A

ICD-9 Finland

Influenza, With pneumonia

+∞

19.8

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

19.7

917

6716

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

19.7

285

1519

ZX112

NOMESCO Finland

Subcutaneous

3.3

19.7

102

318

A07AA09

ATC

vancomycin; oral

4.8

19.6

136

196

Kela drug reimbursment

Paricalcitol and cinacalcet

10.3

19.6

R42

ICD-10 Finland

Dizziness and giddiness

1.5

19.5

778

5518

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.1

19.5

124

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

19.5

656

4482

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.1

19.5

109

359

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

19.5

189

852

C10AA01

ATC

simvastatin; oral

1.4

19.5

1562

12608

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

4.9

19.4

129

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.1

19.3

110

364

A01

ICPC

Pain general/multiple sites

1.9

19.3

288

1554

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

19.2

237

1186

WX402

NOMESCO Finland

General anaesthesia

1.6

19.2

621

4201

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

19.2

839

6067

R01AD08

ATC

fluticasone; nasal

1.4

19.1

1026

7722

J96.9

ICD-10 Finland

Respiratory failure, unspecified

9.0

19.1

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

20.1

19.0

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

19.0

482

3065

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

14.0

19.0

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.1

19.0

182

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

18.9

178

791

B34.9

ICD-10 Finland

Viral infection, unspecified

2.7

18.9

129

482

E000001

ATC

1.5

18.9

755

5357

SPAT1229

SPAT

Assessment of need for aid

1.9

18.8

285

1545

6BA02

NOMESCO Finland

15.9

18.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

18.7

204

969

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

11.8

18.7

R07.3

ICD-10 Finland

Other chest pain

1.8

18.7

335

1926

SPAT1301

SPAT

No procedures

1.4

18.7

1211

9423

D07AA02

ATC

hydrocortisone; topical

1.6

18.6

524

3424

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.5

18.6

143

573

N06AB10

ATC

escitalopram; oral

1.5

18.6

722

5091

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

4.6

18.5

140

R55

ICD-10 Finland

Syncope and collapse

1.7

18.5

395

2396

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

18.5

259

1365

S06.0

ICD-10 Finland

Concussion

1.7

18.5

393

2379

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.9

18.4

197

N05AX08

ATC

risperidone; systemic

1.9

18.4

296

1640

W19

ICD-10 Finland

Unspecified fall

1.8

18.4

355

2086

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.9

18.4

193

J01CA08

ATC

pivmecillinam; oral

1.4

18.3

1291

10184

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.6

18.3

234

R03DC01

ATC

zafirlukast; oral

3.9

18.3

194

K07

ICPC

Swollen ankles/oedema

2.3

18.2

165

720

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

7.2

18.2

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

7.9

18.2

J86.9

ICD-10 Finland

Pyothorax without fistula

11.0

18.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

18.1

432

2700

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

18.1

342

1997

N06AA09

ATC

amitriptyline; systemic

1.8

18.1

337

1961

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

18.1

630

4336

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

14.4

18.0

A12BA01

ATC

potassium chloride; oral

2.3

18.0

169

750

R4190

NOMESCO Finland

Nutritional therapy

2.5

18.0

145

596

B02.9

ICD-10 Finland

Zoster without complication

2.1

18.0

210

1028

J01FA15

ATC

telithromycin; oral

1.7

18.0

353

2087

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

15.3

17.9

B34.2

ICD-10 Finland

Coronavirus infection, unspecified site

7.4

17.9

WZC30

NOMESCO Finland

Teaching

1.6

17.9

472

3036

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

17.8

183

848

Z51.5

ICD-10 Finland

Palliative care

2.1

17.7

206

1007

GDG10

NOMESCO Finland

Bilateral transplantation of lung

66.8

17.7

J01DC02

ATC

cefuroxime; systemic

2.1

17.7

215

1071

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.5

17.6

246

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.2

17.6

179

825

SPAT1260

SPAT

Consultation of another employee

1.5

17.6

667

4672

N04AA02

ATC

biperiden; systemic

3.5

17.5

242

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.8

17.5

116

427

M54.5

ICD-10 Finland

Low back pain

1.4

17.4

1199

9399

P01BA02

ATC

hydroxychloroquine; oral

1.9

17.4

280

1549

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

17.4

709

5040

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.6

17.4

131

518

D07AC01

ATC

betamethasone; topical

1.4

17.4

1252

9886

R52.2

ICD-10 Finland

Other chronic pain

2.6

17.3

128

502

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.6

17.3

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

24.1

17.3

N05BB01

ATC

hydroxyzine; systemic

2.0

17.2

239

1253

K08.3

ICD-10 Finland

Retained dental root

1.9

17.2

261

1419

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.2

17.1

183

862

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

17.1

240

1264

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

9.8

17.1

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.5

17.1

133

537

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.1

17.0

314

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

17.0

861

6392

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.3

16.9

265

K78

ICPC

Atrial fibrillation/flutter

1.9

16.9

266

1462

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.6

16.8

214

A08

ICPC

Swelling

2.3

16.8

153

672

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

35.1

16.6

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

16.6

113

423

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.4

16.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

16.6

258

1410

SPAT1234

SPAT

Support of social functional capacity

2.1

16.6

191

929

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

16.6

131

534

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.2

16.5

148

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.2

16.5

148

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

13.4

16.4

X57

ICD-10 Finland

Unspecified privation

2.9

16.4

100

348

J18

ICD-10 Finland

Pneumonia, organism unspecified

8.6

16.4

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

7.5

16.4

C07AB02

ATC

metoprolol; systemic

1.5

16.3

725

5242

R03BC01

ATC

cromoglicic acid; inhalant

3.4

16.3

230

C01CA24

ATC

epinephrine; parenteral

2.0

16.2

213

1097

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.7

16.2

115

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

16.2

206

1048

RS221

NOMESCO Finland

3.7

16.1

191

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

16.1

240

1294

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.1

16.1

187

915

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.9

16.0

167

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

16.0

191

945

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.0

16.0

158

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.9

15.9

108

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

8.6

15.9

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

8.6

15.9

N03AX14

ATC

levetiracetam; systemic

2.7

15.9

111

422

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

15.8

261

1457

D70.89

ICD-10 Finland

Neutropenic splenomegaly

4.2

15.8

145

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.7

15.8

311

1836

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

15.8

131

547

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.7

15.8

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.6

15.8

A10AA01

ATC

2.6

15.8

114

442

H26.3

ICD-10 Finland

Drug-induced cataract

8.0

15.7

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

15.6

117

463

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.8

15.6

171

ZY000

NOMESCO Finland

Hospital inpatient

3.8

15.5

172

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.7

15.5

187

393

Kela drug reimbursment

Pomalidomide

160.5

15.5

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

15.4

233

1264

T89

ICPC

Diabetes insulin dependent

2.2

15.4

159

740

J11.8

ICD-10 Finland

Influenza with other manifestations, virus not identified

6.8

15.4

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.7

15.3

184

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

15.3

232

1259

N17.8

ICD-10 Finland

Other acute renal failure

4.6

15.3

113

R04.0

ICD-10 Finland

Epistaxis

1.8

15.3

260

1467

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

15.2

142

630

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

5.1

15.2

E87.5

ICD-10 Finland

Hyperkalaemia

3.6

15.2

196

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

15.1

226

1220

J10

ICD-10 Finland

Influenza due to identified seasonal influenza virus

23.4

15.1

120

Kela drug reimbursment

Hypogammaglobulinaemia

23.4

15.1

NHQ40

NOMESCO Finland

Amputation of toe

3.6

15.1

192

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.3

15.0

229

3AC01

NOMESCO Finland

4.4

15.0

125

R31

ICD-10 Finland

Unspecified haematuria

1.6

14.9

359

2248

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

7.3

14.9

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

14.8

814

6116

TFP20

NOMESCO Finland

Cardiodefibrillation

1.8

14.8

256

1452

K77

ICPC

Heart failure

3.2

14.8

248

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

6.2

14.8

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

14.8

643

4623

EBA00

NOMESCO Finland

Extraction of tooth

1.3

14.7

1260

10171

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

25.1

14.7

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

14.6

260

1491

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

14.6

289

1714

N06AX21

ATC

duloxetine; oral

1.6

14.5

355

2232

E86

ICD-10 Finland

Volume depletion

3.0

14.5

284

C09CA01

ATC

losartan; oral

1.4

14.5

813

6127

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

14.5

145

666

GD1UN

NOMESCO Finland

Lung circulation SPECT

6.0

14.5

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.1

14.5

173

857

L04AX06

ATC

pomalidomide; oral

150.4

14.5

A10AA02

ATC

2.3

14.5

139

626

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

2.8

14.4

327

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.0

14.3

179

904

AA1AA

NOMESCO Finland

Head X-ray examination

5.2

14.3

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

14.2

176

885

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.3

14.2

122

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

14.2

1452

12011

N06AB06

ATC

sertraline; oral

1.6

14.1

373

2397

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

14.1

192

1002

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

14.1

539

3771

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

14.1

288

1722

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.2

14.1

236

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

8.0

14.0

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

14.0

256

1481

J98.1

ICD-10 Finland

Pulmonary collapse

6.6

14.0

K59.0

ICD-10 Finland

Constipation

1.9

13.9

193

1015

R52.9

ICD-10 Finland

Pain, unspecified

1.7

13.9

290

1746

YNB10

NOMESCO Finland

Collection of stem cells for transplant

15.8

13.9

ZZA00

NOMESCO Finland

Split skin graft

2.5

13.9

107

433

F05.9

ICD-10 Finland

Delirium, unspecified

3.1

13.9

244

E000002

ATC

1.6

13.8

405

2670

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

13.8

121

521

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

13.8

124

541

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

53.5

13.8

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.6

13.8

101

395

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

6.0

13.7

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

13.7

323

2014

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

13.7

189

992

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.7

13.7

338

WVA20

NOMESCO Finland

Medicine administration

2.7

13.7

356

V03AE03

ATC

lanthanum carbonate; oral

9.7

13.7

N03AF01

ATC

carbamazepine; oral, rectal

2.0

13.6

178

915

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

13.6

302

1848

SPAT1216

SPAT

Assessment of functional ability

1.5

13.6

522

3658

SPAT1104

SPAT

Monitoring of emergency patient

1.8

13.6

238

1357

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

6.9

13.6

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.3

13.5

199

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

13.5

487

3366

A10BB12

ATC

glimepiride; oral

1.8

13.5

244

1405

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

5.0

13.5

1507

Kela drug reimbursment

Pomalidomide

140.4

13.4

C10AA05

ATC

atorvastatin; oral

1.3

13.4

1308

10733

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.5

13.4

107

441

U04

ICPC

Incontinence urine

2.1

13.4

154

753

Z00.8

ICD-10 Finland

Other general examinations

1.7

13.4

263

1557

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

13.4

998

7873

N05AD01

ATC

haloperidol; systemic

2.4

13.4

109

453

N06AB03

ATC

fluoxetine; oral

1.5

13.4

416

2784

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.3

1456

12130

H03AA01

ATC

levothyroxine sodium; systemic

1.4

13.3

749

5642

N02AC04

ATC

dextropropoxyphene; oral

2.2

13.3

134

618

348

Kela drug reimbursment

Roflumilast

21.2

13.3

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

13.3

146

699

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

13.3

466

3203

G04CA02

ATC

tamsulosin; oral

1.4

13.3

814

6225

S01.0

ICD-10 Finland

Open wound of scalp

1.7

13.3

272

1629

Z94.1

ICD-10 Finland

Heart transplant status

11.5

13.3

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.6

13.3

385

ZXD20

NOMESCO Finland

Day surgery

1.5

13.2

455

3111

SPAT1167

SPAT

Insertion of urinary catheter

2.3

13.2

120

529

C02AC05

ATC

moxonidine; oral

2.0

13.2

163

819

H02AB02

ATC

dexamethasone; systemic

1.6

13.1

309

1926

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.2

13.1

136

637

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

13.0

508

3569

WW300

NOMESCO Finland

Transfer of autologic stem cells

7.9

13.0

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.6

13.0

358

I20.09

ICD-10 Finland

Unstable angina

1.9

13.0

201

1097

S29

ICPC

Skin symptom/complaint other

1.4

13.0

580

4185

WX320

NOMESCO Finland

Spinalanesthesy

1.4

13.0

786

5992

M25.5

ICD-10 Finland

Pain in joint

1.3

13.0

974

7685

A05AA02

ATC

ursodeoxycholic acid; oral

3.1

13.0

222

H05BX01

ATC

cinacalcet; oral

6.2

13.0

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.0

13.0

239

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.5

13.0

101

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

12.9

115

499

329

Kela drug reimbursment

Lenalidomide

9.3

12.9

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

12.9

378

2491

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

19.1

12.9

N05AF03

ATC

chlorprothixene; systemic

2.5

12.9

388

1CX01

NOMESCO Finland

22.6

12.9

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.1

12.8

146

712

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

12.8

112

483

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.9

12.8

264

C08CA13

ATC

lercanidipine; oral

1.5

12.8

428

2910

A02BA02

ATC

ranitidine; systemic

1.4

12.8

674

5021

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

12.8

308

1931

J01DA08

ATC

[U] cefaclor; oral

1.5

12.7

428

2913

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

12.7

448

3081

3829X

ICD-9 Finland

Suppurative and unspecified otitis media, Unspecified otitis media

14.1

12.7

WNF00

NOMESCO Finland

Infection source and contact determination

7.2

12.7

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

12.7

154

771

B01AB04

ATC

dalteparin; parenteral

2.0

12.7

168

867

K65.0

ICD-10 Finland

Acute peritonitis

3.6

12.7

157

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

12.7

224

1281

TAB00

NOMESCO Finland

Lumbar puncture

2.0

12.7

157

790

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

12.7

157

790

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

12.6

1388

11553

L01AA01

ATC

cyclophosphamide; systemic

7.5

12.6

C08DB01

ATC

diltiazem; oral

1.9

12.6

188

1014

A10BH05

ATC

linagliptin; oral

2.0

12.6

163

836

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

6.1

12.5

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.3

12.5

110

477

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

12.5

483

3386

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

+∞

12.5

J17.1*B01.2

ICD-10 Finland

Varicella pneumonia

+∞

12.5

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.1

12.5

212

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.7

12.5

309

WX721

NOMESCO Finland

Oxygen concentrator therapy

17.3

12.5

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

12.4

334

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

12.4

287

1779

J01CF05

ATC

flucloxacillin; systemic

2.1

12.4

137

657

D07AB08

ATC

desonide; topical

1.6

12.4

365

2408

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.3

12.4

186

S70.0

ICD-10 Finland

Contusion of hip

2.2

12.4

122

557

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

12.3

214

1216

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

12.3

223

1285

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

12.3

120

547

R06AX13

ATC

loratadine; oral

1.5

12.3

511

3636

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

12.3

1205

9875

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.9

12.3

177

945

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.6

12.2

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.2

12.2

5CM18

NOMESCO Finland

9.0

12.2

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

12.2

361

2385

E87.6

ICD-10 Finland

Hypokalaemia

2.4

12.2

104

442

N03AF02

ATC

oxcarbazepine; oral

2.2

12.2

116

523

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

12.2

190

1042

Z2445

NOMESCO Finland

Psychologist

2.0

12.2

152

771

GBB00

NOMESCO Finland

Tracheostomy

4.2

12.2

108

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

15.9

12.1

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.6

12.1

345

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

12.1

2769

25115

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.1

12.1

128

605

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.1

12.1

138

675

M10

ICD-10 Finland

Gout

2.0

12.1

153

779

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.4

12.1

174

J01.1

ICD-10 Finland

Acute frontal sinusitis

3.2

12.1

201

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

12.1

170

902

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.8

12.0

281

B97.4

ICD-10 Finland

Respiratory syncytial virus as the cause of diseases classified to other chapters

26.7

12.0

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

18.1

12.0

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.6

12.0

347

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

12.0

1808

15621

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.5

12.0

159

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

12.0

177

954

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

12.0

227

1331

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.3

11.9

181

5AB14

NOMESCO Finland

13.4

11.9

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.4

11.9

405

Z72.0

ICD-10 Finland

Tobacco use

2.4

11.9

397

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.8

11.9

265

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.6

11.8

337

R52.0

ICD-10 Finland

Acute pain

2.2

11.8

113

509

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.0

11.8

149

759

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

11.8

295

1869

N04BC05

ATC

pramipexole; oral

1.7

11.7

230

1361

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.2

11.7

113

513

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.4

11.7

403

A02BA04

ATC

nizatidine; systemic

1.7

11.7

262

1612

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

11.7

139

691

N05AC02

ATC

thioridazine; oral

2.8

11.7

269

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

11.7

224

1317

R99

ICPC

Respiratory disease other

2.9

11.6

234

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

11.6

982

7869

L04AA13

ATC

leflunomide; oral

2.6

11.6

336

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

11.6

172

931

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.3

11.6

107

477

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

11.5

334

2195

M05BX04

ATC

denosumab; parenteral

1.9

11.5

155

809

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.6

11.5

139

XQ800

NOMESCO Finland

Prick test

1.7

11.5

243

1470

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

11.5

131

641

S01

ICPC

Pain/tenderness of skin

2.0

11.5

148

758

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.3

11.5

176

J17.1

ICD-10 Finland

Pneumonia in viral diseases classified elsewhere

+∞

11.5

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.1

11.5

105

ZXD35

NOMESCO Finland

Usual procedure

2.1

11.4

121

573

J16.8

ICD-10 Finland

Pneumonia due to other specified infectious organisms

120.3

11.4

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

11.4

367

2474

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.6

11.4

294

1879

RD210

NOMESCO Finland

2.7

11.4

301

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.7

11.4

285

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.4

11.3

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.8

11.3

262

N17

ICPC

Vertigo/dizziness

1.5

11.3

372

2519

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

11.3

221

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.1

11.3

195

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.5

11.3

343

2282

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

11.2

186

1044

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

11.2

323

2120

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

11.2

250

1536

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

11.2

327

2154

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.2

11.1

180

I95.9

ICD-10 Finland

Hypotension, unspecified

3.3

11.1

164

3XA02

NOMESCO Finland

25.1

11.1

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

11.1

123

592

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

11.1

554

4078

L03AA13

ATC

pegfilgrastim; parenteral

2.2

11.1

113

525

A29

ICPC

General symptom/complaint other

1.5

11.1

372

2532

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.3

11.1

420

TK820

NOMESCO Finland

Peritoneal dialysis

6.4

11.1

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

4.6

11.0

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

11.0

361

2441

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.0

11.0

140

714

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

11.0

178

992

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.0

10.9

105

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.9

10.9

110

J11

ICD-10 Finland

Influenza, virus not identified

3.8

10.9

120

I20.00

ICD-10 Finland

Unstable angina

2.2

10.9

110

511

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.0

10.9

129

643

N05AF05

ATC

zuclopenthixol; systemic

4.0

10.8

106

R13

ICD-10 Finland

Dysphagia

1.8

10.8

197

1142

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.6

10.8

283

K02.1

ICD-10 Finland

Caries of dentine

1.2

10.8

2186

19455

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.7

10.8

214

1272

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.5

10.7

137

-1

NOMESCO Finland

1.3

10.7

1243

10373

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.0

10.7

127

632

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.3

10.6

S76

ICPC

Skin infection other

1.8

10.6

166

916

G72.8

ICD-10 Finland

Other specified myopathies

3.2

10.6

165

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

10.6

142

742

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

10.6

1324

11152

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

10.6

2069

18326

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

10.5

2767

25283

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.5

10.5

318

1XC02

NOMESCO Finland

4.7

10.5

J05AH02

ATC

oseltamivir; oral

4.7

10.5

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

10.4

167

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

10.4

102

468

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

7.3

10.4

3A064

NOMESCO Finland

7.3

10.4

47099

ICD-8 Finland

Influenza, unqualified

+∞

10.4

J128, U071

ICD-10 Finland

+∞

10.4

J18.2

ICD-10 Finland

Hypostatic pneumonia, unspecified

+∞

10.4

4829X

ICD-9 Finland

Other bacterial pneumonia, Bacterial pneumonia unspecified

+∞

10.4

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

10.4

129

653

4451

FHL

Guitar cutting

2.0

10.4

131

666

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

4.1

10.4

C03AA03

ATC

hydrochlorothiazide; oral

1.6

10.4

303

1995

WX290

NOMESCO Finland

Other blockade of nerve

1.2

10.4

1653

14308

NH1AD

NOMESCO Finland

Ankle and foot CT

2.7

10.4

257

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

7.7

10.4

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.3

10.4

430

M10.0

ICD-10 Finland

Idiopathic gout

2.1

10.3

108

509

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

4.3

10.3

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

32.6

10.3

L01XE27

ATC

[U] ibrutinib; oral

32.6

10.3

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

32.6

10.3

1XX32

NOMESCO Finland

32.6

10.3

L29

ICPC

Musculoskeletal sympt/complt other

1.6

10.3

237

1471

N05AN01

ATC

lithium; oral

2.4

10.3

345

Z01.7

ICD-10 Finland

Laboratory examination

1.5

10.3

377

2615

S10

ICPC

Boil/carbuncle

1.8

10.3

185

1067

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

10.3

163

904

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.2

10.3

164

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

23.4

10.2

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.5

10.2

321

T82

ICPC

Obesity

2.1

10.2

114

554

Z50.1

ICD-10 Finland

Other physical therapy

1.8

10.2

179

1028

C07AG02

ATC

carvedilol; oral

1.7

10.1

196

1156

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

10.1

158

873

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

10.1

233

1447

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

10.1

408

2887

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

7.9

10.1

I25.2

ICD-10 Finland

Old myocardial infarction

1.7

10.1

218

1331

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

3.2

10.1

161

P29

ICPC

Psychological sympt/compl other

1.7

10.1

192

1130

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

11.3

10.0

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.9

10.0

149

807

R06AX27

ATC

desloratadine; oral

1.3

10.0

938

7609

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

14.6

10.0

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

10.0

115

566

R78

ICPC

Acute bronchitis/bronchiolitis

2.4

10.0

328

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.4

10.0

347

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

3.9

10.0

100

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

7.2

10.0

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.6

9.9

278

N05AX12

ATC

aripiprazole; systemic

1.9

9.9

132

690

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

9.9

117

584

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.6

9.8

272

D11

ICPC

Diarrhoea

1.5

9.8

371

2586

L01BB05

ATC

fludarabine; systemic

12.2

9.8

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

9.8

402

2852

WZA90

NOMESCO Finland

Other doctors statement

1.3

9.8

823

6574

N07BA03

ATC

varenicline; oral

1.8

9.8

159

888

WX204

NOMESCO Finland

Axillary plexus blockaced

2.1

9.8

107

515

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

9.8

394

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

9.8

109

528

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.1

9.8

170

U07

ICPC

Urine symptom/complaint other

1.7

9.8

184

1077

R03AC18

ATC

indacaterol; inhalant

4.7

9.8

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

9.8

693

5401

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.7

9.7

112

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.7

9.7

196

1173

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

9.7

626

4810

M48.0

ICD-10 Finland

Spinal stenosis

1.5

9.7

375

2628

A10AE06

ATC

insulin degludec; parenteral

2.1

9.7

108

523

ED1AA

NOMESCO Finland

Mandipular X-ray examination

4.9

9.7

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.2

9.7

443

PE1AT

NOMESCO Finland

Femoral artery PTA

3.5

9.7

123

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

7.4

9.7

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

9.7

277

1818

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.1

9.7

J01XX08

ATC

linezolid; systemic

6.1

9.7

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.0

9.6

178

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

9.6

264

1714

R28

ICPC

Limited function/disability (R)

3.3

9.6

140

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

3.9

9.6

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

8.4

9.5

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.7

9.5

231

C01BD01

ATC

amiodarone; systemic

2.2

9.5

428

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.6

9.5

266

C08CA05

ATC

nifedipine; systemic

1.7

9.5

212

1305

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.4

9.5

329

S20.2

ICD-10 Finland

Contusion of thorax

1.8

9.5

162

923

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

5.7

9.5

R4180

NOMESCO Finland

Podiatric therapy

3.6

9.5

115

R29

ICPC

Respiratory symptom/complaint other

1.7

9.5

200

1212

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.3

9.5

136

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.4

9.5

584

4456

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

9.4

1502

12963

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.0

9.4

169

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

9.4

205

1255

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

9.4

126

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.1

9.4

457

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

9.4

317

2157

K92.1

ICD-10 Finland

Melaena

1.8

9.4

168

968

N06AX05

ATC

trazodone; oral

2.3

9.4

362

C08DA01

ATC

verapamil; systemic

1.9

9.4

138

746

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.3

9.4

137

J14

ICD-10 Finland

Pneumonia due to Haemophilus influenzae

+∞

9.4

J15.2

ICD-10 Finland

Pneumonia due to staphylococcus

+∞

9.4

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.9

9.4

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.0

9.4

115

582

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

9.4

425

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.4

9.4

306

L14

ICPC

Leg/thigh symptom/complaint

1.6

9.3

241

1540

E87.7

ICD-10 Finland

Fluid overload

21.7

9.3

2AX04

NOMESCO Finland

21.7

9.3

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

21.7

9.3

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

9.3

258

1677

H05AA02

ATC

teriparatide; parenteral

5.8

9.3

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.6

9.3

246

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.5

9.3

122

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.0

9.3

108

535

I95.2

ICD-10 Finland

Hypotension due to drugs

4.4

9.3

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

9.3

131

697

ZX121

NOMESCO Finland

Central venous catheter

6.9

9.3

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

9.3

490

3643

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.5

9.3

300

U02

ICPC

Urinary frequency/urgency

1.4

9.2

401

2875

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.1

9.2

467

XG460

NOMESCO Finland

Short time oxymetry

2.7

9.2

217

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.9

9.2

188

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.5

9.2

291

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.8

9.2

201

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

9.2

182

R01

ICPC

Pain respiratory system

2.9

9.2

182

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.6

9.2

113

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.6

9.2

259

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

4.3

9.2

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.9

9.2

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

2.8

9.2

211

A07EA06

ATC

budesonide; oral, local oral

2.0

9.2

107

531

RF220

NOMESCO Finland

2.9

9.2

189

318

Kela drug reimbursment

Teriparatide

5.4

9.2

UJD02

NOMESCO Finland

Gastroscopy

1.8

9.2

153

862

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

13.7

9.2

J04.0

ICD-10 Finland

Acute laryngitis

2.0

9.2

111

558

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.9

9.1

183

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.0

9.1

162

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

9.1

162

933

N05AA01

ATC

chlorpromazine; systemic, rectal

2.9

9.1

184

I26

ICD-10 Finland

Pulmonary embolism

3.8

9.1

R2110

NOMESCO Finland

Giving the first information

1.6

9.1

213

1332

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

9.0

252

1646

N06AX03

ATC

mianserin; oral

1.8

9.0

150

845

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

9.0

312

2138

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

9.0

775

6211

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

8.9

414

R03BC03

ATC

nedocromil; inhalant

1.6

8.9

216

1360

R03DX07

ATC

roflumilast; oral

18.6

8.9

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.0

8.9

4659X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Unspecified site

2.2

8.9

385

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

8.9

203

1260

SPAT1101

SPAT

Orthostatic test

1.8

8.9

147

827

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

8.9

102

501

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

8.9

285

TPX15

NOMESCO Finland

Removal of vascular injection port

5.5

8.9

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

5.7

8.9

KMAK

NOMESCO Finland

1.2

8.9

1923

17107

WX213

NOMESCO Finland

Lower leg blockade

4.2

8.8

L12

ICPC

Hand/finger symptom/complaint

1.4

8.8

457

3383

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

8.8

336

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

8.8

347

2441

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.2

8.8

400

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

6.8

8.8

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.6

8.8

107

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.7

8.8

219

RS224

NOMESCO Finland

4.6

8.8

R04

ICPC

Breathing problem other

2.0

8.7

112

575

U13

ICPC

Bladder symptom/complaint other

2.1

8.7

450

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.1

8.7

R01AD12

ATC

fluticasone furoate; nasal

1.3

8.7

995

8259

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

5.9

8.7

M03BX01

ATC

baclofen; systemic

2.7

8.7

214

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

7.2

8.7

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

8.7

284

1924

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.2

8.7

406

390

Kela drug reimbursment

Ibrutinib

14.0

8.7

1512

Kela drug reimbursment

Ibrutinib

14.0

8.7

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

8.7

431

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.7

8.7

215

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.0

8.7

107

542

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.8

8.6

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

4.8

8.6

SPAT1252

SPAT

Overall medication plan or its review

1.6

8.6

221

1411

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

8.6

233

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.3

8.6

334

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

8.6

213

1348

A49

ICD-10 Finland

Bacterial infection of unspecified site

7.6

8.6

WX110

SPAT

1.7

8.6

163

959

-69

ICPC

Other reason for encounter NEC

1.8

8.6

132

727

Z29

ICPC

Social problem NOS

2.4

8.6

306

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

8.6

296

2025

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

3.7

8.6

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

3.7

8.6

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.3

8.6

N05CF02

ATC

zolpidem; oral

1.3

8.6

551

4226

H01AC01

ATC

somatropin; parenteral

5.8

8.6

SPAT1211

SPAT

Application of soft bandage

1.5

8.6

304

2093

S16

ICPC

Bruise/contusion

2.0

8.6

100

497

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

8.6

135

750

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

11.6

8.6

SPAT1325

SPAT

Vaccination

1.2

8.6

1229

10471

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.6

8.5

228

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.0

8.5

102

512

C02CA01

ATC

prazosin; oral

2.4

8.5

279

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.0

8.5

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.7

8.5

167

992

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

9.0

8.5

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

8.5

144

820

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.8

8.5

U14

ICPC

Kidney symptom/complaint

2.7

8.5

198

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

27.5

8.5

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

2.4

8.5

283

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.8

8.5

136

760

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1.9

8.5

112

584

B80

ICPC

Iron deficiency anaemia

2.5

8.4

266

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

2.9

8.4

170

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

8.4

141

797

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.6

8.4

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

8.4

254

1692

GDC00

NOMESCO Finland

Lobectomy of lung

4.7

8.4

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

8.4

188

1163

J94.8

ICD-10 Finland

Other specified pleural conditions

2.8

8.4

193

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

8.4

313

2181

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

8.4

968

8045

48601

ICD-8 Finland

More specifically, unspecified pneumonia and the pleural irritation caused by it

+∞

8.3

J15.0

ICD-10 Finland

Pneumonia due to Klebsiella pneumoniae

+∞

8.3

S21

ICPC

Skin texture symptom/complaint

1.4

8.3

402

2941

R06AX22

ATC

ebastine; oral

1.3

8.3

537

4122

H3600, E103

ICD-10 Finland

2.9

8.3

173

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.2

8.3

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.8

8.3

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

5.8

8.3

R25.1

ICD-10 Finland

Tremor, unspecified

2.0

8.3

478

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

8.2

136

767

D07XC01

ATC

betamethasone, combinations; topical

1.4

8.2

379

2747

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.0

8.2

100

507

SPAT1097

SPAT

Recording of ECG

1.4

8.2

479

3618

I63.8

ICD-10 Finland

Other cerebral infarction

3.6

8.2

R03

ICPC

Wheezing

3.2

8.2

130

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.2

8.2

130

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.9

8.2

161

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

8.2

186

1155

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.2

8.2

344

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.4

8.2

285

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

8.2

146

843

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.6

8.2

215

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.1

8.2

136

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

8.1

126

697

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

8.1

325

Z94.4

ICD-10 Finland

Liver transplant status

6.0

8.1

C09DX04

ATC

valsartan and sacubitril; oral

3.9

8.1

F21

ICPC

3.9

8.1

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

5.7

8.1

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

3.8

8.1

399

Kela drug reimbursment

Venetoclax

33.4

8.1

SPAT1172

SPAT

Guidance concerning hydration

2.2

8.1

351

ZX197

NOMESCO Finland

17.2

8.1

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.6

8.1

186

1156

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

4.2

8.1

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

8.1

154

909

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

8.0

650

5157

SPAT1057

SPAT

Peak expiratory flow measurement

2.3

8.0

320

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

8.0

279

1915

L76

ICPC

Fracture: other

2.1

8.0

408

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

10.0

8.0

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.3

8.0

116

N30

ICD-10 Finland

Cystitis

1.6

8.0

219

1426

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.1

8.0

400

R03AC19

ATC

olodaterol; inhalant

6.3

8.0

A99

ICPC

Disease/condition unspecnature/site

1.5

8.0

246

1646

J93.9

ICD-10 Finland

Pneumothorax, unspecified

5.2

8.0

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.0

8.0

144

RS222

NOMESCO Finland

2.9

8.0

159

S28

ICPC

Limited function/disability (S)

5.9

8.0

E83.50

ICD-10 Finland

Hypercalcemia

3.1

8.0

133

Y96.9

ICD-10 Finland

Unspecified type of accident

2.4

8.0

275

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.7

7.9

189

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.8

7.9

135

768

L29.9

ICD-10 Finland

Pruritus, unspecified

2.2

7.9

347

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.8

7.9

173

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.3

7.9

117

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

7.9

246

SPAT1281

SPAT

Other administrative function

1.5

7.9

263

1789

L88

ICPC

Rheumatoid/seropositive arthritis

1.9

7.9

110

586

N05BA12

ATC

alprazolam; oral

1.4

7.9

317

2238

4741B

ICD-9 Finland

Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PHARYNGICAE]

2.5

7.9

231

SPAT1310

SPAT

Counselling related to known health issue

1.2

7.9

1141

9709

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

7.9

173

1062

N18

ICD-10 Finland

Chronic kidney disease

3.4

7.9

107

F20.5

ICD-10 Finland

Residual schizophrenia

4.9

7.9

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

13.0

7.9

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

13.0

7.9

N29

ICPC

Neurological sympt/complt other

2.4

7.9

278

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.7

7.9

183

WX212

NOMESCO Finland

Femoral plexus blockade

2.4

7.9

259

K99

ICPC

Cardiovascular disease other

2.1

7.9

396

C09CA03

ATC

valsartan; oral

1.5

7.9

268

1832

J43.2

ICD-10 Finland

Centrilobular emphysema

7.7

7.9

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

7.7

7.9

XF602

NOMESCO Finland

Bloodpressure monitoring

2.9

7.9

154

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

7.8

176

1089

L84

ICD-10 Finland

Corns and callosities

1.9

7.8

107

564

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

4.0

7.8

E000003

ATC

1.7

7.8

143

832

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

6.1

7.8

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.8

7.8

129

730

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.3

7.8

113

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

5.4

7.8

EBA30

NOMESCO Finland

Excision of root of tooth

1.6

7.8

177

1099

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.6

7.8

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.6

7.8

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

7.8

332

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.0

7.8

141

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

7.8

177

1101

K56.0

ICD-10 Finland

Paralytic ileus

3.4

7.8

103

Angiography of the heart and coronary arteries

1.6

7.8

196

1251

212

Kela drug reimbursment

Gout

2.3

7.7

293

R06.4

ICD-10 Finland

Hyperventilation

2.5

7.7

236

SPAT1125

SPAT

Stoma care and guidance

2.6

7.7

200

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.8

7.7

133

759

L01XX52

ATC

venetoclax; oral

45.0

7.7

B37.7

ICD-10 Finland

Candidal sepsis

15.0

7.7

7AX01

NOMESCO Finland

15.0

7.7

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

15.0

7.7

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2.6

7.7

212

R03BB06

ATC

glycopyrronium bromide; inhalant

6.4

7.7

UJF92

NOMESCO Finland

Capsular endoscopy

2.3

7.7

295

D07AD01

ATC

clobetasol; topical

1.3

7.7

482

3684

5BA08

NOMESCO Finland

4.6

7.7

XF622

NOMESCO Finland

Measurement of minute volume of heart

5.9

7.7

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.6

7.7

205

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.5

7.7

H36.01

ICD-10 Finland

Diabetic maculopathy

2.8

7.6

159

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.0

7.6

143

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

7.6

376

JAH00

NOMESCO Finland

Laparotomy

2.0

7.6

437

NF3AA

NOMESCO Finland

Femur X-ray examination

2.3

7.6

290

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.2

7.6

116

398

Kela drug reimbursment

Ixazomib

25.0

7.6

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

25.0

7.6

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.1

7.6

402

WX720

NOMESCO Finland

Own respiration

1.8

7.6

121

679

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.8

7.5

115

634

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.8

7.5

161

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

3.6

7.5

XX4BW

NOMESCO Finland

8.8

7.5

WX740

NOMESCO Finland

Nitrogen oxide therapy

6.1

7.5

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

6.1

7.5

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.6

7.5

198

1276

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

7.5

284

1987

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

7.5

418

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.2

7.5

117

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.2

7.5

117

M03BX02

ATC

tizanidine; oral

1.2

7.5

2216

20173

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.8

7.5

162

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

7.5

216

1423

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

7.5

303

2147

L03

ICPC

Low back symptom/complaint

1.3

7.5

785

6442

N06AX26

ATC

vortioxetine; oral

1.6

7.5

180

1135

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

7.1

7.5

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

7.5

329

2368

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

7.5

430

3245

XX9XE

NOMESCO Finland

Other ultrasound examination

3.5

7.5

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.5

7.5

D06BB03

ATC

aciclovir; topical

1.7

7.5

143

845

S22.3

ICD-10 Finland

Fracture of rib

1.6

7.4

197

1270

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.8

7.4

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.4

7.4

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.6

7.4

187

N05BE01

ATC

buspirone; oral

2.0

7.4

450

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.3

7.4

299

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

7.4

388

P72

ICPC

Schizophrenia

2.4

7.4

259

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

13.4

7.4

R5110

SPAT

2.0

7.4

424

N01

ICPC

Headache

1.4

7.4

348

2536

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

5.3

7.4

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

6.0

7.4

J01MA06

ATC

norfloxacin; oral

1.4

7.4

401

2995

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

4.5

7.4

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.3

7.3

108

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

7.3

247

1686

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.2

7.3

302

WW804

NOMESCO Finland

Transfer from treating institution to higher-Level care, accompanied by doctor

8.4

7.3

4661A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchiolitis

8.4

7.3

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

4.7

7.3

S51.9

ICD-10 Finland

Open wound of forearm, part unspecified

3.1

7.3

125

4810A

ICD-9 Finland

Pneumococcal pneumonia[PNEUMONIA PNEUMOCOCCICA]

+∞

7.3

Z99.2

ICD-10 Finland

Dependence on renal dialysis

10.9

7.3

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

7.3

348

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

7.3

511

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

9.4

7.3

F2680

NOMESCO Finland

9.4

7.3

M10.3

ICD-10 Finland

Gout due to impairment of renal function

4.9

7.3

P18

ICPC

Medication abuse

4.0

7.2

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

7.2

705

5728

NDG30

NOMESCO Finland

Fusion of wrist, total

4.5

7.2

M05BA07

ATC

risedronic acid; oral

2.0

7.2

475

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.6

7.2

D01AC02

ATC

miconazole; topical

1.5

7.2

253

1739

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

7.2

500

3877

B37.0

ICD-10 Finland

Candidal stomatitis

3.3

7.2

104

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.5

7.2

219

N05AB03

ATC

perphenazine; systemic, rectal

1.8

7.2

110

606

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

4.3

7.2

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.9

7.2

148

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

4.6

7.2

Y94.0

ICD-10 Finland

Accident at home

2.4

7.2

247

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.8

7.2

112

624

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.6

7.2

172

1082

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

7.2

211

1397

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

7.2

221

280

Kela drug reimbursment

Clopidogrel

2.5

7.2

203

ZX114

NOMESCO Finland

Intramuscular

2.5

7.2

203

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

7.2

232

1573

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

7.2

110

610

ZX196

NOMESCO Finland

30.0

7.1

K90

ICPC

Stroke/cerebrovascular accident

2.0

7.1

402

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.1

7.1

367

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.4

7.1

248

F61.0

ICD-10 Finland

Mixed personality disorders

2.4

7.1

248

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

4.8

7.1

N0832, E102

ICD-10 Finland

20.0

7.1

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

20.0

7.1

R06AE09

ATC

levocetirizine; oral

1.3

7.1

467

3596

A03FA02

ATC

cisapride; oral, rectal

1.5

7.1

233

1583

K50.8

ICD-10 Finland

Other Crohn disease

2.5

7.1

214

1240

FHL

Bronchoscopy

3.0

7.1

122

D02AX

ATC

Other emollients and protectives

1.9

7.1

105

572

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.3

7.1

272

L04AA05

ATC

[U] tacrolimus; systemic

12.0

7.1

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

7.1

153

938

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

6.0

7.1

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.3

7.0

282

R10.0

ICD-10 Finland

Acute abdomen

1.9

7.0

532

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

7.0

136

809

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.6

7.0

25008

ICD-8 Finland

Diabetes mellitus, Complicatio alia definita

10.0

7.0

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.5

7.0

199

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

7.0

208

1382

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.3

7.0

B07.9

ICD-10 Finland

Verruca simplex

1.8

7.0

116

659

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

7.0

167

1051

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.4

7.0

218

SPAT1251

SPAT

Organisation of medication

1.8

7.0

108

598

M13.0

ICD-10 Finland

Polyarthritis, unspecified

2.8

7.0

152

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.2

6.9

102

H02AA02

ATC

fludrocortisone; oral

3.6

6.9

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.4

6.9

238

Y07

ICD-10 Finland

Other maltreatment

3.7

6.9

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.5

6.9

222

1501

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.5

6.9

201

UDC00

NOMESCO Finland

Ear microscopy

1.5

6.9

235

1608

S20

ICPC

Corn/callosity

2.3

6.9

269

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

5.1

6.9

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

5.1

6.9

S90.0

ICD-10 Finland

Contusion of ankle

2.2

6.9

290

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

6.9

902

7582

K02.9

ICD-10 Finland

Dental caries, unspecified

2.4

6.9

239

J04AB02

ATC

rifampicin; systemic

2.7

6.9

170

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.4

6.9

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

6.9

169

1071

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.6

6.9

187

S17

ICPC

Abrasion/scratch/blister

2.0

6.8

399

P99

ICPC

Psychological disorders other

2.0

6.8

399

T74.1

ICD-10 Finland

Physical abuse

2.2

6.8

293

602

Kela drug reimbursment

Children's severe malnutrition

4.8

6.8

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

8.3

6.8

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.8

6.8

112

632

49099

ICD-8 Finland

Bronchitis, unspecified

2.7

6.8

155

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

6.7

6.8

L20.0

ICD-10 Finland

Besnier prurigo

1.5

6.8

214

1439

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.0

6.8

376

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

5.0

6.8

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

9.3

6.8

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

9.3

6.8

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

6.8

444

GD1FN

NOMESCO Finland

Lung ventilation isotope imaging

40.1

6.8

U08

ICD-10 Finland

Personal history of COVID-19

5.3

6.8

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

5.6

6.7

F05.8

ICD-10 Finland

Other delirium

3.7

6.7

E23.02

ICD-10 Finland

Neurosecretory dysfunction of the growth hormone

16.7

6.7

T21.3

ICD-10 Finland

Burn of third degree of trunk

16.7

6.7

R4130

NOMESCO Finland

Speech therapy

2.1

6.7

321

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.9

6.7

488

R51

ICD-10 Finland

Headache

1.6

6.7

155

970

A11

ICPC

Chest pain NOS

1.5

6.7

225

1533

7803A

ICD-9 Finland

General symptoms, Convulsions

2.6

6.7

167

N06AA12

ATC

doxepin; systemic

1.6

6.7

153

953

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

6.7

177

1145

WYA20

NOMESCO Finland

Home visit

2.5

6.7

192

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

7.2

6.7

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.8

6.7

106

595

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.7

6.7

124

730

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

6.7

146

900

B37.08

ICD-10 Finland

Other candidal stomatitis

3.5

6.7

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.5

6.7

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

22.5

6.7

V07AB

ATC

Solvents and diluting agents, incl. irrigating solutions

22.5

6.7

U01

ICPC

Dysuria/painful urination

1.5

6.7

217

1470

A98

ICPC

Health maint/preventive medicine

1.3

6.7

4208

40835

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.7

6.7

144

883

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

6.7

507

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.6

6.7

159

1004

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.8

6.7

113

648

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

3.7

6.6

CKC12

NOMESCO Finland

Photocoagulation of retina

1.7

6.6

125

737

U05

ICPC

Urination problems other

1.7

6.6

137

830

IAB11

NOMESCO Finland

Psychiatric mood consultation

6.4

6.6

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.5

6.6

194

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.8

6.6

542

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

2.9

6.6

123

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

5.1

6.6

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.9

6.6

442

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.3

6.6

232

WW409

NOMESCO Finland

Other aferesis

7.8

6.6

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

7.8

6.6

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

6.6

123

724

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

6.6

107

605

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

5.5

6.6

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.2

6.6

PD3AT

NOMESCO Finland

Pelvic artery PTA

4.2

6.6

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.0

6.6

416

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.7

6.6

163

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

12.2

6.6

GX2C5

NOMESCO Finland

Short-lasting oximetry

12.2

6.6

N083, E102

ICD-10 Finland

12.2

6.6

29599

ICD-8 Finland

Schizophrenia, Unspecified type

4.6

6.6

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

1.6

6.6

172

1108

183

Kela drug reimbursment

Lamotrigin and topiramate

3.0

6.6

118

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.5

6.6

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.0

6.6

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

6.6

110

627

WX723

NOMESCO Finland

CPAP therapy

1.8

6.6

108

611

NFQ20

NOMESCO Finland

Amputation of femur

3.6

6.6

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

3.9

6.5

L50.0

ICD-10 Finland

Allergic urticaria

2.0

6.5

354

UGB02

NOMESCO Finland

Tracheoscopy

8.7

6.5

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

8.7

6.5

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.6

6.5

164

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

6.5

271

1931

K04.0

ICD-10 Finland

Pulpitis

1.4

6.5

308

2248

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.5

6.5

189

29560

ICD-8 Finland

Residual schizophrenia

10.0

6.5

EB1AA

SPAT

1.6

6.5

151

945

WW200

SPAT

0.7

6.5

175

2541

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

6.5

272

1939

A01AB04

ATC

amphotericin B; local oral

1.6

6.5

141

868

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.7

6.5

157

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

5.0

6.5

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

5.0

6.5

N05AL01

ATC

sulpiride; systemic

2.4

6.5

209

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.2

6.5

268

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.3

6.4

239

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.5

6.4

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

6.4

388

K28

ICPC

Limited function/disability (K)

2.1

6.4

315

R07.1

ICD-10 Finland

Chest pain on breathing

2.4

6.4

202

J01GB01

ATC

tobramycin; inhalant, parenteral

69.9

6.4

PB1AT

NOMESCO Finland

Upper extremity artery PTA

69.9

6.4

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.2

6.4

269

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.2

6.4

261

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

6.4

220

1511

XKD00

NOMESCO Finland

Uroflowmetry

1.3

6.4

528

4199

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

2.6

6.4

167

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

6.4

167

P03

ICPC

Feeling depressed

1.4

6.4

276

1980

J15.7

ICD-10 Finland

Pneumonia due to Mycoplasma pneumoniae

14.3

6.4

R80

ICPC

Influenza

2.9

6.4

130

A10BJ06

ATC

semaglutide; parenteral

1.9

6.4

476

J01MA01

ATC

ofloxacin; systemic

1.4

6.4

262

1867

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

3.6

6.4

A10BK03

ATC

empagliflozin; oral

1.5

6.4

203

1371

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

2.3

6.3

254

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

6.3

431

3334

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.1

6.3

D12

ICPC

Constipation

1.8

6.3

102

574

SPAT1053

SPAT

Memory test

1.3

6.3

458

3577

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

6.3

409

3145

N07BC02

ATC

methadone; systemic

5.9

6.3

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

11.0

6.3

UGC02

NOMESCO Finland

Rigid bronchoscopy

5.5

6.3

R35

ICD-10 Finland

Polyuria

1.5

6.3

189

1262

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

6.3

1967

17899

R05DB20

ATC

other cough suppressants - combinations

1.5

6.3

175

1146

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

6.3

292

2126

A04AA02

ATC

granisetron; systemic, transdermal

1.6

6.3

161

1035

7151

FHL

Kidney transplantation

18.0

6.3

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

3.8

6.3

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

6.3

102

578

XG405

NOMESCO Finland

Education on PEF monitoring

2.4

6.2

218

PG5YT

NOMESCO Finland

Stenting of arteriovenous fistula

+∞

6.2

4828X

ICD-9 Finland

Other bacterial pneumonia, Pneumonia due to other specified bacteria

+∞

6.2

47101

ICD-8 Finland

Influenza with pneumonia, Cum pleuropneumonia

+∞

6.2

J17.3

ICD-10 Finland

Pneumonia in parasitic diseases

+∞

6.2

48298

ICD-8 Finland

Other bacterial pneumonia, Other

+∞

6.2

B37.1

ICD-10 Finland

Pulmonary candidiasis

+∞

6.2

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

+∞

6.2

GBB03

NOMESCO Finland

Percutaneous tracheostomy

26.7

6.2

JL9AE

NOMESCO Finland

Ultrasound examination of pancreas transplant

26.7

6.2

B97.2

ICD-10 Finland

Coronavirus as the cause of diseases classified to other chapters

26.7

6.2

D64.8

ICD-10 Finland

Other specified anaemias

2.3

6.2

219

R25.2

ICD-10 Finland

Cramp and spasm

2.1

6.2

327

S72.0

ICD-10 Finland

Fracture of neck of femur

1.8

6.2

100

565

K04.08

ICD-10 Finland

Other specified pulpit

1.5

6.2

197

1330

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.6

6.2

146

917

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

6.2

1413

12517

-44

ICPC

Preventive immunization/medic

1.4

6.2

257

1833

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.2

6.2

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.8

6.2

105

602

N06AA06

ATC

trimipramine; systemic

2.0

6.2

355

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.0

6.2

381

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

6.2

336

2513

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.9

6.2

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.2

6.2

M02AA07

ATC

piroxicam; topical

1.2

6.2

1207

10552

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

6.3

6.1

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.3

6.1

232

N07BB01

ATC

disulfiram; oral

1.6

6.1

136

844

L60.0

ICD-10 Finland

Ingrowing nail

1.6

6.1

144

907

101

Kela drug reimbursment

Anterior pituitary hypofunction

3.3

6.1

C02EA02

ATC

1.6

6.1

134

828

R40.2

ICD-10 Finland

Coma, unspecified

3.1

6.1

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

6.1

2088

19115

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

1.8

6.1

499

B37.8

ICD-10 Finland

Candidiasis of other sites

7.7

6.1

SPAT1077

SPAT

Arterial blood sampling

7.7

6.1

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.7

6.1

136

A10BJ02

ATC

liraglutide; parenteral

2.1

6.1

310

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

6.1

319

2373

C09BA02

ATC

enalapril and diuretics; systemic

1.4

6.1

254

1814

I49.5

ICD-10 Finland

Sick sinus syndrome

1.7

6.1

106

614

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.1

624

5102

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

6.1

151

962

F2682

NOMESCO Finland

12.5

6.1

H05BX02

ATC

paricalcitol; systemic

12.5

6.1

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

12.5

6.1

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

6.1

118

704

C10AA03

ATC

pravastatin; oral

1.5

6.1

210

1446

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.6

6.1

L52

ICD-10 Finland

Erythema nodosum

3.7

6.1

R03BB07

ATC

umeclidinium bromide; inhalant

3.7

6.1

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.0

6.1

108

T92

ICPC

Gout

2.1

6.1

277

S09.9

ICD-10 Finland

Unspecified injury of head

2.6

6.0

161

M79.1

ICD-10 Finland

Myalgia

1.3

6.0

388

2978

H04AA01

ATC

glucagon; nasal, parenteral

1.8

6.0

475

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.8

6.0

523

L88

ICD-10 Finland

Pyoderma gangrenosum

10.0

6.0

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

6.7

6.0

J94.2

ICD-10 Finland

Haemothorax

6.7

6.0

742

NOMESCO Finland

6.7

6.0

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

6.0

555

S09

ICPC

Infected finger/toe

1.8

6.0

524

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013650) Neutrophils [#/volume] in Blood by Automated count

3836

23572

3.12

320.87

15.8

8.0

e9/l

4.6

4.0

33.61

3410

20375

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

324

279

12.28

319.44

1.9

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1132

3449

3.88

319.22

15.8

7.1

g/l

121.9

122.7

0.56

1077

3328

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

773

1800

4.84

311.19

17.6

9.0

mmol/l

24.8

24.0

7.98

738

1692

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

243

129

19.67

311.18

2.2

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

332

310

11.34

310.31

2.0

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3496

20666

2.93

309.22

10.1

5.6

umol/l

10.8

12.1

9.39

3353

19506

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

576

616

10.34

307.65

2.3

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1801

6019

3.98

307.65

5.3

3.1

mmol/l

0.8

0.19

1707

5593

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

423

435

10.46

307.65

2.4

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

3526

19700

3.24

307.65

10.7

5.6

24.5

28.8

73.29

3413

18286

(3000991) Gas panel - Venous blood

1097

3103

4.17

307.65

16.3

7.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1182

3374

4.20

307.65

13.3

6.8

mmol/l

10.5

9.3

5.72

1142

3201

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2467

5228

7.80

307.65

2.7

1.6

—

(3006315) Basophils [#/volume] in Blood

3608

20328

3.30

307.65

9.9

5.4

e9/l

0.0

2.21

3140

17432

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

568

440

14.30

307.65

1.6

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1140

3204

4.24

307.65

14.1

6.7

mmol/l

1.4

1.3

0.33

1101

3081

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1877

3506

7.64

307.65

2.5

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1439

4891

3.64

307.65

10.9

5.5

mmol/l

1.1

1.0

2.76

1364

4556

(3001604) Monocytes [#/volume] in Blood

3595

20238

3.29

307.65

9.9

5.4

e9/l

0.6

14.06

3127

17351

(3019069) Monocytes/100 leukocytes in Blood

3487

19071

3.30

307.65

10.9

5.8

8.4

8.7

4.87

3376

17798

(3019198) Lymphocytes [#/volume] in Blood

3651

20914

3.26

307.65

10.0

5.4

e9/l

2.0

1.9

0.50

3221

18292

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1391

4233

4.07

307.65

5.6

3.9

u/l

259.0

239.4

4.71

1340

3977

(3016502) Oxygen saturation in Arterial blood

1252

3689

4.11

307.65

14.7

6.9

94.1

96.2

18.83

1184

3565

(3006504) Eosinophils/100 leukocytes in Blood

3484

18950

3.33

307.65

10.6

5.6

2.2

2.9

60.68

3368

17586

(3022096) Basophils/100 leukocytes in Blood

3439

18363

3.37

307.65

10.5

5.6

0.5

0.7

50.96

3329

17064

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1858

7520

3.23

307.65

5.5

3.3

ng/l

303.1

604.1

1.34

1528

5769

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

696

1108

7.06

307.65

3.1

3.0

g/l

4.6

3.4

47.04

680

1049

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

568

440

14.30

307.65

1.6

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

407

403

10.83

307.65

2.0

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

541

613

9.69

307.65

2.4

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1867

3507

7.58

307.65

2.4

1.5

—

(3013115) Eosinophils [#/volume] in Blood

3677

21038

3.30

307.65

10.8

5.6

e9/l

0.2

9.40

3238

18329

(42870588) Differential panel, method unspecified - Blood

2908

13497

3.48

307.65

9.8

5.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

369

332

11.85

307.65

2.2

1.3

—

(3003396) Base excess in Arterial blood by calculation

1426

4058

4.41

307.65

13.4

6.6

mmol/l

1.5

0.7

9.83

1166

3085

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1426

4051

4.41

307.65

13.7

6.6

kpa

5.1

5.0

1.49

1347

3896

(3023368) Bacteria identified in Blood by Culture

3227

9283

7.08

307.65

7.0

3.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

836

1150

8.41

307.65

2.6

1.8

ug/l

1.3

2.8

1.60

751

983

(3018010) Neutrophils/100 leukocytes in Blood

3479

19416

3.19

307.65

10.3

5.5

61.0

56.4

76.05

3364

18116

(3027801) Oxygen [Partial pressure] in Arterial blood

1424

4050

4.41

307.65

13.7

6.6

kpa

10.5

13.1

73.15

1344

3896

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2289

8462

3.94

307.65

3.1

1.7

mg/l

1.3

1.2

0.97

1957

6282

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

350

357

10.41

307.63

1.9

1.2

—

(3002032) Base excess in Venous blood by calculation

1116

3497

3.76

300.72

6.2

4.0

mmol/l

2.0

1.7

1.70

929

2811

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

317

292

11.47

298.90

2.3

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

883

2364

4.26

296.79

6.7

3.7

kpa

5.2

5.1

1.91

825

2169

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1113

3517

3.72

295.83

6.2

3.9

kpa

5.9

5.8

3.25

1067

3428

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3146

17866

2.80

295.61

14.1

5.4

mmol/l

1.2

41.22

2933

16106

(3009343) pH of Capillary blood

870

2329

4.26

292.23

6.8

3.8

7.4

3.50

181

251

(3012544) pH of Venous blood

1130

3645

3.65

290.81

6.4

3.9

7.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3362

19861

2.81

290.54

15.7

5.9

mmol/l

1.2

30.41

2926

16737

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

849

2242

4.30

290.32

6.7

3.7

mmol/l

2.4

1.3

13.65

686

1600

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

885

2501

4.03

275.17

2.0

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3791

24280

2.85

271.90

11.1

4.1

mmol/l

7.1

6.7

23.25

3640

22553

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

435

675

6.92

270.04

8.9

5.0

iu/ml

7815.6

637.2

0.51

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

506

918

5.97

268.92

3.4

2.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

211

117

18.72

264.59

1.3

1.0

—

(3023419) Bacteria identified in Sputum by Culture

278

261

11.17

258.47

3.0

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

470

825

6.14

258.25

1.3

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

469

839

6.02

252.61

5.8

2.9

mmol/l

25.1

24.4

2.69

418

730

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

769

2110

4.08

247.84

2.1

1.5

—

(3019060) Gas panel - Arterial blood

800

2269

3.96

246.10

6.6

4.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2959

17312

2.55

245.50

8.0

4.5

g/l

33.4

36.0

91.67

2780

16060

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

733

1975

4.13

241.96

17.3

9.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

537

1135

5.14

240.62

3.8

3.3

u/ml

0.3

0.92

293

624

(3014576) Chloride [Moles/volume] in Serum or Plasma

1249

4826

3.06

234.93

15.3

6.3

mmol/l

104.1

104.7

4.58

1209

4732

(3028626) Oxygen [Partial pressure] in Capillary blood

471

907

5.59

234.21

6.0

4.4

kpa

8.1

8.7

8.82

445

844

(3021901) Oxygen saturation in Capillary blood

376

590

6.77

230.41

5.0

2.5

—

(44806118)

270

302

9.35

221.00

2.2

1.3

—

(44790048)

270

302

9.35

221.00

2.2

1.3

—

(44790049)

270

302

9.35

221.00

2.2

1.3

—

(44790047)

270

302

9.35

221.00

2.2

1.3

—

(1616796) Gas panel - Central venous blood

411

742

5.91

218.71

5.9

3.1

—

(3002582) Erythrocytes [#/volume] in Urine

2260

12277

2.44

211.57

4.9

3.1

e6/l

33.9

103.4

3.78

1809

9310

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

772

2360

3.65

211.34

9.3

7.7

mmol/l

25.0

24.5

2.75

766

2346

(3032080) INR in Blood by Coagulation assay

2744

16305

2.38

208.64

13.9

8.4

inr

1.2

1.3

0.59

812

4619

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2086

11045

2.44

205.40

4.5

2.8

ng/l

2434.6

1324.7

10.87

1872

9380

(3042936) Bacteria identified in Isolate by Culture

1287

5404

2.81

204.93

2.7

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

850

2821

3.39

204.42

4.7

2.4

g/l

9.4

10.7

11.35

805

2567

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

665

1879

3.89

204.03

5.7

4.6

mmol/l

24.3

24.0

1.54

628

1694

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

330

517

6.73

202.20

4.4

3.1

u/ml

2752.9

2094.4

0.09

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1405

6210

2.70

202.10

3.3

2.1

30.5

29.8

3.33

1360

6016

(3018418) pH of Serum or Plasma

2119

11389

2.41

200.74

7.7

3.6

7.4

1.57

468

2141

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2911

18022

2.32

197.44

4.1

2.7

ug/l

269.9

120.9

11.79

2765

16699

(3033658) Prothrombin time (PT) actual/Normal

1957

10292

2.41

193.18

6.9

3.8

87.7

89.4

1.92

1924

10030

(3030467) Casts [#/volume] in Urine by Automated count

2074

11195

2.38

192.88

4.6

3.0

e6/l

0.5

0.4

1.65

1607

8322

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

686

2071

3.65

190.49

1.6

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

853

2974

3.22

188.31

5.4

3.5

kpa

4.9

4.6

2.98

814

2894

(3018095) Leukocytes [#/volume] in Urine

2471

14482

2.29

188.26

5.8

3.5

e6/l

96.5

91.3

0.07

1863

10054

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

737

2352

3.47

187.79

19.7

8.1

1.3

1.47

729

2337

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

735

2342

3.47

187.73

19.8

8.2

0.6

0.7

4.32

727

2324

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

203

195

10.77

185.40

2.3

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

339

603

5.93

182.75

1.9

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3839

27220

2.39

182.57

6.7

4.2

e6/l

98.0

1985.4

4.13

369

(3014007) Fractional oxyhemoglobin in Arterial blood

729

2351

3.43

182.46

20.0

8.2

92.6

94.3

8.42

724

2339

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4279

31859

2.60

182.39

13.2

6.6

u/l

82.6

78.2

6.86

4140

29874

(3026008) Bacteria identified in Urine by Culture

2088

11546

2.31

181.00

4.1

3.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1105

4553

2.79

180.15

2.3

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1213

5301

2.66

175.70

4.0

2.4

21.2

23.7

7.82

1052

4522

(3022948) Iron [Moles/volume] in Serum or Plasma

1345

6199

2.55

174.43

3.9

2.3

umol/l

11.6

13.7

20.14

1257

5736

(36304419) Bacteria [Presence] in Urine

1992

10944

2.29

173.84

4.6

2.9

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

120

26.08

173.24

1.3

1.4

ng/l

101.7

16.4

4.44

102

(40767503) Oxygen content in Capillary blood by calculation

364

733

5.25

171.30

4.5

2.2

16.0

16.6

1.39

229

369

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

136

12.56

168.18

2.1

1.2

—

(3026782) Osmolality of Urine

1557

7797

2.40

167.52

4.0

2.6

mosm/kgh2o

532.0

557.6

4.59

1387

6568

(3027945) Reticulocytes/100 erythrocytes in Blood

1059

4424

2.73

166.99

4.1

2.5

1.9

1.7

5.71

968

3888

(3000850) Epithelial cells [#/volume] in Urine

1631

8350

2.36

166.73

4.0

2.5

e6/l

5.9

5.2

1.34

1474

7250

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

199

216

9.52

166.33

3.8

3.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1255

5711

2.56

166.26

3.9

2.3

g/l

2.2

2.4

10.43

1180

5282

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

138

16.44

163.08

1.4

1.1

—

(3021589) Normoblasts [#/volume] in Blood

2850

18432

2.15

161.79

17.5

8.6

e9/l

0.0

0.78

2272

15035

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

212

265

8.28

158.50

2.3

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

370

820

4.77

155.36

3.5

2.1

g/l

128.1

131.0

1.12

280

600

(3008152) Bicarbonate [Moles/volume] in Arterial blood

676

2299

3.22

153.99

10.2

6.0

mmol/l

25.2

24.2

7.16

615

2152

(40758558) Short blood count panel - Blood

1825

10092

2.22

152.71

11.0

6.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

654

2199

3.24

151.74

3.0

1.8

g/l

1.4

0.11

601

2019

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

219

302

7.51

150.52

2.3

1.5

—

(3022313) Gas panel - Capillary blood

568

1759

3.49

150.36

6.9

3.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

501

1428

3.76

150.30

3.1

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

812

3121

2.88

148.86

4.4

2.6

ng/l

257.9

177.6

4.47

744

2805

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

182

204

9.20

148.37

2.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

182

204

9.20

148.37

2.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

182

204

9.20

148.37

2.2

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3888

28902

2.21

147.05

6.4

4.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

109

21.37

145.68

1.8

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

348

775

4.73

145.11

6.9

3.3

kpa

8.4

8.8

4.27

340

760

(3013290) Carbon dioxide [Partial pressure] in Blood

347

774

4.72

144.40

6.9

3.3

kpa

5.0

4.9

1.02

339

759

(3012501) Base excess in Blood by calculation

347

774

4.72

144.40

6.9

3.3

mmol/l

2.6

2.4

0.89

257

469

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

143

118

12.42

144.14

2.3

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

446

1209

3.93

143.64

3.0

2.8

91.7

90.3

0.64

430

1126

(3017181) Myelocytes/100 leukocytes in Blood

817

3217

2.81

142.78

5.4

3.9

1.0

0.9

0.17

388

780

(3010421) pH of Blood

377

909

4.38

142.21

6.9

3.3

7.4

0.94

340

760

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

142

119

12.23

141.75

2.3

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1306

6453

2.35

141.62

3.8

2.8

e6/l

2.4

2.2

0.28

743

3524

(3028271) Lactate [Moles/volume] in Capillary blood

283

540

5.47

141.12

2.9

1.7

mmol/l

1.6

1.8

2.14

277

526

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3762

27864

2.13

139.81

3.7

3.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

398

1018

4.14

138.79

1.5

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1805

10287

2.13

136.90

2.8

2.1

mg/l

3.1

2.9

3.07

1584

8775

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2182

13360

2.06

136.36

4.3

3.1

u/l

38.1

33.6

0.47

2077

12658

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

461

1326

3.71

136.12

2.6

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

410

1092

3.98

135.18

3.2

2.9

211.1

182.3

7.79

397

1039

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

530

1685

3.38

134.12

2.2

1.6

g/l

1.6

1.5

2.95

466

1423

(3015377) Calcium [Moles/volume] in Serum or Plasma

2171

13338

2.04

133.74

4.6

3.0

mmol/l

2.3

2.4

25.92

1943

11614

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2020

12094

2.07

133.57

2.8

2.0

u/l

271.8

214.7

0.82

1923

11345

(3004809) Band form neutrophils/100 leukocytes in Blood

274

536

5.33

132.84

4.2

3.3

1.1

1.4

0.87

208

403

(3036489) Thrombin time

479

1458

3.51

129.68

2.8

2.4

21.7

21.5

0.38

447

1266

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2369

15153

2.00

128.99

5.9

3.3

ng/l

146.4

83.1

0.34

1796

10141

(3020630) Protein [Mass/volume] in Serum or Plasma

758

3043

2.73

126.74

4.3

2.2

g/l

64.6

66.9

10.85

696

2739

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2036

12498

2.00

123.24

3.6

2.4

u/l

54.2

59.2

3.25

1897

11513

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1321

6901

2.21

123.11

3.6

2.7

e6/l

1.0

1.2

0.63

754

3939

(3021440) Promyelocytes/100 leukocytes in Blood

756

3093

2.68

121.48

5.5

3.9

0.1

0.20

372

723

(3009445) Proteinase 3 Ab [Units/volume] in Serum

468

1467

3.40

120.78

1.7

1.6

u/ml

11.5

13.8

0.18

(3002179) Metamyelocytes/100 leukocytes in Blood

729

2938

2.71

120.64

5.1

3.7

0.7

0.6

0.36

282

565

(3023520) Reticulocytes [#/volume] in Blood

786

3306

2.61

119.30

3.9

2.5

e9/l

71.5

68.2

1.56

569

2484

(3026250) Tacrolimus [Mass/volume] in Blood

137

151

9.28

113.02

43.5

35.3

ug/l

7.3

7.4

0.29

126

139

(3000494) Fungus identified in Specimen by Culture

953

4520

2.34

110.81

1.9

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

2046

12972

1.92

109.49

3.7

2.2

—

(3011412) CD3 cells [#/volume] in Blood

191

319

6.17

109.40

2.5

2.7

e9/l

1.0

1.2

2.92

129

170

(3036481) Cortisol [Moles/volume] in Serum or Plasma

788

3463

2.49

108.45

2.6

2.2

nmol/l

339.5

376.6

5.02

716

3179

(3047181) Lactate [Moles/volume] in Blood

382

1125

3.58

108.36

9.1

5.1

mmol/l

1.4

1.3

0.69

328

996

(3027273) Bicarbonate [Moles/volume] in Venous blood

500

1753

3.04

106.67

6.6

3.0

mmol/l

25.5

25.1

1.60

471

1701

(3004119) Hemoglobin [Mass/volume] in Venous blood

590

2320

2.73

101.64

6.2

3.3

g/l

125.0

130.6

6.89

565

2262

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

207

403

5.30

100.71

7.3

6.3

mg/l

11.7

0.05

186

376

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

157

237

6.79

99.19

2.2

2.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1324

7441

2.03

98.83

2.0

1.7

nmol/l

1144.9

1161.4

0.24

1050

5578

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

116

123

9.61

98.48

2.4

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

116

123

9.61

98.48

2.4

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

116

123

9.61

98.48

2.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

116

123

9.61

98.48

2.4

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1396

8010

2.00

98.20

2.2

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

613

2526

2.61

95.95

4.0

2.0

—

(4010399)

626

2607

2.58

95.88

1.6

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

172

295

5.99

95.85

2.3

2.5

43.0

43.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

158

249

6.51

95.80

2.1

2.5

12.2

12.5

0.08

130

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4951

43073

2.65

95.79

35.3

11.5

mg/l

32.1

22.0

78.70

4620

33261

(1175426) CD3 cells/100 lymphocytes in Blood

159

254

6.42

95.14

2.1

2.5

71.0

71.3

0.08

152

243

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2724

19536

1.79

93.42

5.6

3.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

377

1212

3.27

92.87

2.9

2.2

ug/l

1116.8

747.2

0.24

362

1150

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

447

1589

2.98

92.70

7.7

4.1

mmol/l

25.3

24.5

5.31

425

1458

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

291

792

3.83

92.54

1.8

1.4

—

(3025159) Blasts/100 leukocytes in Blood

673

2951

2.46

92.23

5.5

4.0

0.0

0.4

1.30

304

615

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

431

1512

3.01

91.48

8.0

4.4

1.7

1.6

0.67

384

1429

(3007930) Methemoglobin/Hemoglobin.total in Blood

427

1495

3.01

90.94

8.2

4.4

0.9

0.21

382

1413

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1258

7126

2.00

90.81

3.3

2.8

mmol/l

2.5

2.4

6.11

1116

6241

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

778

3667

2.31

90.43

3.1

2.4

u/l

33.2

53.2

0.90

675

3171

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2404

16735

1.78

90.25

2.3

1.9

pmol/l

92.0

95.6

3.56

1341

8833

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

274

732

3.89

89.44

1.9

1.4

u/ml

140.9

112.7

0.53

142

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

288

797

3.76

89.38

1.8

1.4

u/ml

12.4

15.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

731

3380

2.34

88.75

2.9

2.2

ug/l

9.0

7.8

0.52

626

2945

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

637

2781

2.46

87.92

6.6

3.8

ng/l

116.0

84.0

9.18

562

2395

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

331

1015

3.41

87.91

2.0

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1597

9893

1.87

87.60

3.4

2.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

954

4945

2.13

87.41

2.1

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

985

5174

2.10

87.12

30.3

24.6

inr

1.5

1.4

1.08

154

759

(3013707) Erythrocyte sedimentation rate by Westergren method

3848

30905

1.84

86.68

6.2

3.7

mm/h

17.0

10.9

70.69

3668

28538

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2371

16595

1.76

86.08

2.9

2.2

nmol/l

73.2

76.7

7.22

2158

14931

(3042631) Mycobacterium sp identified in Specimen

187

382

5.03

86.07

3.1

2.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

344

1096

3.28

85.89

5.3

2.9

mg/l

50.6

58.9

0.21

267

903

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

337

1067

3.30

84.99

5.1

2.8

ratio

5.8

2.7

0.30

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

356

1168

3.19

84.66

2.0

1.6

titre

318.2

316.2

0.00

(3034860) Kappa light chains.free [Mass/volume] in Serum

341

1100

3.24

83.39

5.3

2.9

mg/l

102.3

104.0

0.01

265

904

(3026493) Urate [Moles/volume] in Serum or Plasma

1682

10733

1.82

82.99

4.4

2.5

umol/l

3253.3

5335.3

1.51

1499

9305

(40757373) Influenza virus identified in Isolate

18.55

82.96

2.0

1.2

—

(3024928) Oxygen saturation in Venous blood

278

796

3.63

81.97

4.7

3.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1472

9114

1.84

79.53

7.1

4.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

111

146

7.74

79.34

34.6

24.4

ug/l

123.8

126.8

0.14

123

(3008757) Leukocyte morphology finding [Identifier] in Blood

174

363

4.92

78.12

4.6

3.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

866

4504

2.10

77.89

4.1

2.9

umol/l

8.3

8.6

0.17

754

3922

(3021879) Hepatitis B virus core Ab [Presence] in Serum

666

3165

2.26

75.10

1.6

1.4

—

(3039000) Anion gap in Blood

270

807

3.47

74.51

10.2

6.0

mmol/l

11.7

11.4

0.54

226

733

(3018572) Chloride [Moles/volume] in Blood

270

808

3.46

74.36

10.2

6.0

mmol/l

103.2

105.5

9.41

226

734

(3007164) IgA [Mass/volume] in Serum or Plasma

1310

7991

1.84

73.35

2.1

1.4

g/l

2.4

0.00

873

4827

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

440

1760

2.63

72.48

4.7

3.0

0.7

0.6

0.23

435

1675

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

726

3621

2.16

72.47

2.6

2.3

g/l

0.2

0.29

665

3382

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

280

873

3.33

72.26

1.9

1.5

—

(3037756) Immunofixation for Serum or Plasma

250

727

3.56

71.94

2.2

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

541

2396

2.40

71.72

1.6

1.2

u/ml

281.9

197.4

0.85

498

2212

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

781

4028

2.10

71.37

5.5

3.0

—

(3042733) HLA Ab [Presence] in Serum

113

8.36

71.01

4.9

4.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

260

785

3.43

70.60

1.5

1.3

u/ml

273.3

247.9

0.67

177

489

(3008536) Aspergillus sp Ab [Presence] in Serum

15.41

69.98

2.3

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

266

820

3.36

69.88

5.8

2.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

9.17

69.88

2.1

1.8

u/ml

60021.6

39682.4

0.11

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

1414

2.78

69.85

3.2

1.9

g/l

3.7

3.8

0.29

274

987

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

295

969

3.16

69.84

1.6

1.4

iu/ml

4.4

12.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

1415

2.78

69.75

3.2

1.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

1415

2.78

69.75

3.2

1.9

g/l

7.5

7.3

1.56

285

1033

(3019550) Sodium [Moles/volume] in Serum or Plasma

4914

43795

2.25

69.40

38.5

13.8

mmol/l

139.1

139.7

46.48

4863

42587

(3042111) Morphology [Interpretation] in Bone marrow Narrative

224

621

3.72

69.21

1.8

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

266

828

3.33

68.80

1.5

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

169

383

4.52

68.60

1.6

1.4

g/l

30.3

32.3

1.13

150

354

(3017354) Segmented neutrophils/100 leukocytes in Blood

157

339

4.74

67.64

3.8

3.2

63.8

56.8

2.22

204

(3035350) Ketones [Presence] in Urine by Test strip

2710

20519

1.64

67.37

5.0

3.4

estimate

0.0

1.08

568

3728

(3048929) Epstein Barr virus Ab [Presence] in Serum

358

1340

2.79

67.06

1.4

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1113

6612

1.86

67.05

2.0

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

159

350

4.65

66.91

1.2

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4916

43948

2.22

66.75

39.0

13.9

mmol/l

4.0

0.16

4860

42658

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

353

1320

2.79

66.23

3.3

2.0

g/l

3.2

3.0

3.31

280

1013

(3021960) Folate [Moles/volume] in Serum or Plasma

1466

9485

1.75

66.18

1.8

1.5

nmol/l

19.3

20.4

1.90

1320

8118

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

352

1316

2.79

66.06

3.1

2.0

g/l

9.9

10.2

0.52

299

1093

(3009261) Glucose [Presence] in Urine by Test strip

2730

20786

1.63

65.74

5.0

3.4

estimate

0.0

0.09

547

3672

(3024980) IgG subclass 4 [Mass/volume] in Serum

208

570

3.75

65.34

1.4

1.7

g/l

0.6

0.8

2.60

154

443

(3021601) Nitrite [Presence] in Urine by Test strip

2700

20540

1.62

64.94

6.8

4.6

estimate

0.0

0.50

579

3788

(3040151) Glucose [Moles/volume] in Capillary blood

176

435

4.15

63.84

46.6

7.0

mmol/l

7.4

7.1

0.63

161

360

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

128

244

5.35

63.70

2.4

2.7

e6/l

508.3

477.9

0.31

190

(3002385) Erythrocyte distribution width [Ratio]

4210

35950

1.75

63.28

37.6

14.7

14.1

13.6

60.48

4168

35119

(3023199) Leukocytes [#/volume] in Pleural fluid

151

334

4.62

63.17

1.6

1.3

e6/l

1409.1

2081.5

0.95

113

241

(3023183) Ammonium ion [Moles/volume] in Plasma

246

770

3.30

63.02

4.3

3.0

umol/l

32.1

34.7

1.01

213

655

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

8.96

62.27

2.3

2.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

109

183

6.06

62.06

2.6

32.9

39.0

1.27

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

295

1044

2.93

61.23

2.1

1.5

g/l

0.2

0.30

281

994

(3000492) Spirometry study

720

3816

2.02

60.44

1.8

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

403

1684

2.50

60.37

7.5

3.6

52.3

47.9

2.83

396

1663

(3028192) IgG subclass 2 [Mass/volume] in Serum

148

336

4.50

59.94

1.3

g/l

2.6

3.1

1.84

106

242

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

8.25

59.80

2.9

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

8.25

59.80

2.9

1.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

121

234

5.27

59.27

2.5

2.7

e9/l

0.2

1.47

100

188

(3024139) IgG subclass 3 [Mass/volume] in Serum

147

336

4.47

59.03

1.3

g/l

0.4

0.15

104

241

(3027135) IgG subclass 1 [Mass/volume] in Serum

147

336

4.47

59.03

1.3

g/l

6.5

6.6

0.06

103

240

(4062490)

147

336

4.47

59.03

1.4

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

908

5244

1.88

59.03

1.5

1.3

titre

584.3

491.1

0.64

183

1017

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

298

1083

2.85

58.90

2.1

1.5

g/l

1.2

0.19

287

1032

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

306

1132

2.80

58.49

5.6

5.1

mg/l

1.9

1.4

13.61

287

1043

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

8.14

58.43

3.0

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

320

1214

2.74

58.29

3.8

2.1

g/l

1.2

1.0

0.29

273

1030

(3028308) Erythrocytes [#/volume] in Pleural fluid

137

300

4.66

58.03

1.6

1.3

e6/l

42347.1

93435.8

0.96

171

(21494814) CD8 cells/100 lymphocytes in Specimen

116

7.34

57.54

2.2

2.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3475

28537

1.60

57.45

4.4

3.0

u/l

55.3

46.2

8.37

3272

26639

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

183

503

3.73

57.23

1.7

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

9.42

57.16

1.3

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

217

670

3.33

56.80

1.7

1.6

—

(3019977) pH of Arterial blood

102

176

5.89

56.48

2.9

2.1

7.4

0.51

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

123

252

4.97

56.41

2.7

2.4

e6/l

621.7

680.3

0.30

101

(3036782) Glucose [Moles/volume] in Pleural fluid

125

260

4.90

56.32

1.5

1.4

mmol/l

6.9

6.3

1.40

120

245

(3012441) Differential panel - Pleural fluid

134

296

4.62

56.16

1.6

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

17.44

54.93

2.6

1.2

—

(40768446) Kidney Pathology biopsy report

145

6.22

52.23

2.0

1.6

—

(3045788) Cell count panel - Pleural fluid

119

255

4.75

51.76

1.6

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

115

6.96

51.62

4.5

3.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

323

1325

2.53

50.16

1.5

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

161

445

3.70

49.94

2.5

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

155

421

3.76

49.32

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

202

652

3.18

49.16

1.5

1.2

titre

36.0

114.5

—

(3028433) Virus identified in Specimen by Culture

100

7.28

49.08

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

275

1058

2.68

48.66

3.2

1.9

g/l

0.1

0.0

0.09

256

960

(3009508) Creatinine [Moles/volume] in Urine

1814

13197

1.56

48.33

4.2

3.2

mmol/l

7.1

7.9

8.79

1515

11141

(3052851) Hemolysis interference index of Serum or Plasma

278

1081

2.66

48.16

3.6

3.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

203

670

3.11

47.57

3.4

3.0

nmol/l

0.8

0.26

158

499

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

212

722

3.01

47.06

5.1

3.5

58.7

56.6

1.24

212

722

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

277

1094

2.61

46.49

3.1

1.9

g/l

36.0

38.3

6.61

247

922

(3020682) Albumin/Creatinine [Ratio] in Urine

1745

12685

1.55

46.17

4.9

3.9

mg/mmol

19.5

9.3

3.97

1180

8120

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

250

947

2.72

45.58

2.2

2.0

mg/l

13.3

10.7

0.76

234

872

(3035880) pH of Pleural fluid

131

6.10

45.57

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

9.39

45.36

3.3

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

253

968

2.69

45.24

3.2

2.0

g/l

0.0

0.50

234

876

(3018405) Lactate [Moles/volume] in Arterial blood

312

1322

2.44

45.15

6.1

3.5

mmol/l

1.4

0.02

299

1305

(3011397) Hemoglobin [Presence] in Urine by Test strip

1386

9613

1.59

44.76

4.4

3.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

590

3221

1.93

44.74

7.4

3.3

mmol/l

1.2

8.77

553

2781

(3009542) Hematocrit [Volume Fraction] of Blood

4484

40060

1.68

44.61

34.1

13.0

38.8

40.2

17.91

3215

29359

(3024932) HLA-DR beta [Type]

124

6.20

44.56

1.1

—

(40768806) Pleura Pathology biopsy report

125

314

4.05

44.39

1.7

1.5

—

(3012516) Albumin [Mass/volume] in Urine

1664

12055

1.55

44.31

4.2

3.2

mg/l

743.7

319.4

2.24

1161

7674

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

193

4.99

44.03

1.4

1.3

u/l

10.5

12.6

0.74

186

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

248

953

2.68

43.96

3.2

2.0

g/l

0.0

0.00

234

875

(3024471) HLA-A [Type]

127

6.05

43.51

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

114

274

4.23

42.95

2.6

1.7

mg/l

4.5

4.2

0.34

104

263

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

143

405

3.60

42.81

1.4

1.2

—

(3044889) 12 lead EKG panel

3460

29276

1.50

42.62

5.0

3.6

—

(3045142) Bone marrow Pathology biopsy report

145

417

3.54

42.42

1.6

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

101

223

4.60

42.39

1.6

1.2

u/ml

1.6

1.1

0.17

(3020891) Body temperature

336

1513

2.30

42.33

7.8

4.2

—

(3025941) Bacteria identified in Stool by Culture

445

2250

2.06

41.87

1.4

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

141

5.60

41.17

1.9

2.7

13.3

12.6

0.11

133

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

124

329

3.83

40.83

4.1

2.7

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

138

5.57

39.93

1.9

2.5

32.0

28.3

1.18

132

(3052592) Norovirus Ag [Presence] in Stool

9.13

39.48

1.5

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

7.98

39.17

1.8

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

159

5.16

39.07

5.0

3.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.40

38.56

6.0

7.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

181

4.81

38.27

1.8

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

181

4.81

38.27

1.8

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

6.84

38.12

2.2

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

103

258

4.05

36.76

1.5

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

333

1587

2.17

36.48

2.2

1.9

u/l

36.0

39.1

2.02

297

1399

(3009466) Valproate [Moles/volume] in Serum or Plasma

160

544

3.00

35.64

7.2

4.9

umol/l

403.1

364.6

2.49

138

469

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

221

4.26

35.61

1.8

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

227

4.20

35.24

1.8

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3696

32229

1.46

34.92

4.4

3.8

pmol/l

14.8

0.44

3421

29220

(3016650) Hepatitis A virus Ab [Presence] in Serum

175

633

2.82

34.85

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4326

38940

1.54

34.85

5.4

4.5

mu/l

1.9

2.0

1.17

4026

35675

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

114

323

3.58

34.15

1.4

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

107

293

3.71

33.72

1.2

1.3

titre

200.0

197.0

0.01

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

127

5.33

33.63

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4936

45997

1.78

33.31

17.9

9.3

u/l

29.6

27.0

3.90

4839

44283

(3000060) B lymphocytes [#/volume] in Blood

110

5.60

32.32

1.8

2.7

e6/l

1372.3

260.6

0.47

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

195

4.31

32.28

1.4

1.2

u/l

100.5

82.8

0.84

164

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

115

342

3.41

32.01

1.3

1.2

u/l

65.6

61.4

0.24

232

(3043409) Potassium [Moles/volume] in Arterial blood

254

1147

2.27

31.73

6.7

3.7

mmol/l

3.9

0.23

218

1086

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

202

830

2.49

31.21

1.8

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

136

4.98

31.15

1.2

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4397

40002

1.52

30.85

28.9

11.4

ml/min/173m2

80.4

82.3

4.88

3748

32653

(3017569) Oxygen content in Arterial blood

158

4.60

30.52

2.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

156

571

2.78

30.41

1.1

—

(3004451) EKG impression Narrative

180

4.32

30.15

1.5

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

164

4.50

30.06

1.5

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

155

571

2.76

29.86

1.5

1.2

u/ml

6.5

4.6

0.26

183

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

146

522

2.85

29.75

1.4

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

258

1205

2.20

29.70

1.6

iu/ml

0.7

7.2

0.68

244

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

219

955

2.35

29.68

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

212

912

2.38

29.63

1.4

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

188

4.19

29.36

1.3

1.2

u/l

29.7

17.8

1.49

157

(40761511) CBC panel - Blood by Automated count

4836

45095

1.65

28.93

27.9

11.4

—

(21494434) Karyotype in Bone marrow

110

340

3.28

28.83

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

389

2141

1.88

28.39

4.5

2.6

e6/l

0.3

0.06

384

2092

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

149

559

2.71

27.73

1.5

1.2

u/ml

4.6

4.1

0.22

238

(3013512) EKG study

1535

11786

1.42

27.69

5.3

3.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

8.59

27.50

13.9

8.8

mmol/l

4.7

6.4

2.08

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

153

588

2.65

27.16

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

15.06

27.08

2.0

1.4

umol/l

41.4

37.9

0.18

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

222

1013

2.24

27.06

1.4

1.3

—

(3003181) Sodium [Moles/volume] in Urine

156

612

2.59

26.58

2.5

1.4

mmol/l

64.5

63.9

0.06

127

494

(3014148) Varicella zoster virus Ab [Titer] in Serum

141

534

2.68

25.78

1.1

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1178

8720

1.45

25.65

1.8

1.7

pmol/l

12088411.8

26993948.6

0.58

1001

7261

(4268621)

113

382

3.00

25.51

2.8

2.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

219

1029

2.18

24.85

1.5

mg/l

723.0

536.7

0.76

205

975

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

162

669

2.47

24.81

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

11.96

24.72

1.4

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1451

11246

1.40

24.16

4.9

3.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

197

904

2.22

23.71

1.6

e6/l

641.9

1094.4

0.56

166

737

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

197

905

2.22

23.64

1.5

1.6

e6/l

26.6

15.9

0.39

160

698

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

10.92

23.32

1.6

1.2

—

(3007461) Platelets [#/volume] in Blood

5094

48552

1.76

23.13

45.6

17.9

e9/l

248.9

247.3

0.85

5011

47209

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

258

3.33

23.01

1.5

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

103

4.89

22.91

3.2

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

103

4.89

22.91

3.2

1.9

—

(3035941) MCH [Entitic mass]

5095

48582

1.76

22.85

45.3

17.8

30.1

30.3

7.40

5064

47849

(3024731) MCV [Entitic volume]

5095

48586

1.76

22.79

45.4

17.8

91.0

90.7

3.01

5064

47851

(3026361) Erythrocytes [#/volume] in Blood

5095

48593

1.75

22.68

45.5

17.8

e12/l

4.4

4.5

68.85

5007

47116

(3010813) Leukocytes [#/volume] in Blood

5096

48608

1.75

22.64

45.6

17.9

e9/l

7.6

6.7

37.02

5010

47122

(3000963) Hemoglobin [Mass/volume] in Blood

5095

48609

1.75

22.44

45.9

17.9

g/l

131.0

137.0

122.33

5066

47885

(21494890) Protein electrophoresis panel - 24 hour Urine

106

372

2.89

22.43

2.4

1.8

—

(4035726)

525

3357

1.62

22.41

1.6

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

110

4.67

22.14

1.5

59.4

69.6

1.00

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

193

909

2.16

21.79

1.4

mmol/l

3.9

3.7

1.15

179

849

(40761536) Microorganisms panel - Urine sediment

538

3500

1.60

21.35

6.3

3.6

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

11.62

21.34

1.6

mg/l

4.1

6.5

0.35

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

11.62

21.34

1.6

mg/l

1.5

2.7

0.28

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

11.62

21.34

1.6

mg/l

3.8

1.0

1.14

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

11.62

21.34

1.6

mg/l

3.1

0.8

0.68

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.62

21.34

4.5

5.6

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

11.62

21.34

1.6

mg/l

3.0

6.2

0.69

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

11.62

21.34

1.6

mg/l

1.1

1.9

0.26

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

154

675

2.32

20.70

5.6

2.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

164

3.81

20.65

8.6

5.3

mg/l

56.7

66.8

0.69

112

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

11.04

20.65

1.6

mg/l

3.9

0.8

1.04

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

133

548

2.46

20.53

1.2

1.1

119.8

116.3

0.50

124

496

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.33

20.52

1.6

1.9

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

8.22

20.49

1.6

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

120

4.28

19.90

8.6

6.8

mmol/l

25.6

24.8

0.69

107

(3044290) Cell count panel - Cerebral spinal fluid

175

825

2.16

19.74

1.4

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

380

2323

1.68

19.28

3.2

3.3

pmol/l

4.4

4.5

1.24

340

2056

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1047

7935

1.40

19.26

1.7

1.5

—

(3003338) MCHC [Mass/volume]

4069

37417

1.35

19.25

39.3

15.4

g/l

330.9

333.3

45.73

4045

37084

(3035947) Staphylolysin Ab [Units/volume] in Serum

164

3.69

19.10

1.3

1.1

iu/ml

5.0

4.2

—

(4015189)

5.68

18.96

3.2

1.9

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

11.15

18.87

1.3

1.4

—

(3017704) Immunofixation for Urine

185

3.49

18.75

1.9

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

116

469

2.51

18.67

1.7

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

105

4.41

18.67

3.4

2.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

901

6687

1.42

18.66

1.3

iu/ml

39.2

30.3

0.99

284

2017

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

7.33

18.64

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

144

3.85

18.62

3.0

—

(3048689) Calprotectin [Mass/mass] in Stool

721

5138

1.46

18.60

2.5

2.4

ug/g

153.3

131.3

0.81

586

4056

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

172

3.58

18.56

1.4

1.6

—

(4306422)

132

569

2.35

18.48

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

106

4.37

18.45

1.3

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

120

497

2.45

18.35

2.0

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

370

2.68

18.14

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

144

651

2.24

18.04

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4190

38831

1.34

17.86

7.3

5.5

mmol/mol

41.9

39.4

34.94

3947

36018

(3011648) Oxygen content in Venous blood

341

2.73

17.66

3.8

5.3

10.7

11.4

0.75

341

(3003740) Influenza virus B Ag [Presence] in Specimen

143

652

2.23

17.56

1.2

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

160

3.59

17.48

1.9

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

160

3.59

17.48

1.9

1.3

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

7.06

17.36

3.0

5.5

mg/l

1.8

2.7

1.18

(3024522) Salmonella sp identified in Specimen by Organism specific culture

117

492

2.41

17.33

2.0

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

379

2.61

17.31

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

9.16

17.31

1.3

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

491

3283

1.54

17.18

3.2

2.5

ml/min/173m2

55.6

67.8

6.74

202

1280

(3008295) Osmolality of Serum or Plasma

381

2.60

17.14

1.5

1.4

mosm/kgh2o

281.1

281.3

0.02

291

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1901

15958

1.29

17.12

5.6

3.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

116

489

2.40

17.10

2.0

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

216

1161

1.90

16.97

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

214

1148

1.90

16.91

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

390

2.57

16.86

1.7

1.3

iu/ml

22.0

24.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

136

618

2.23

16.86

2.4

2.0

—

3.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.66

16.77

1.6

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

130

581

2.27

16.77

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

249

1405

1.81

16.77

4.6

3.1

g/l

0.5

0.3

0.52

145

595

(3051651) Icteric interference index of Serum or Plasma

199

3.24

16.76

4.1

3.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

215

1159

1.89

16.74

2.1

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

10.03

16.69

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

123

538

2.32

16.69

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

114

484

2.38

16.55

4.0

2.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

840

6286

1.40

16.41

1.3

1.2

u/ml

13.9

11.2

0.40

265

2468

(3021788) Differential panel - Synovial fluid

144

678

2.15

16.36

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

114

487

2.37

16.33

2.0

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

215

1169

1.87

16.31

1.2

1.1

—

(40768797) Stomach Pathology biopsy report

747

5483

1.42

16.30

1.3

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

117

3.96

16.24

1.5

1.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

114

489

2.36

16.18

2.0

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1175

9294

1.34

16.12

1.3

u/ml

1.5

2.0

0.84

294

2411

(3005988) Vibrio sp identified in Specimen by Organism specific culture

114

490

2.35

16.11

2.0

1.3

—

(3016038) Potassium [Moles/volume] in Urine

241

2.97

16.05

3.0

1.3

mmol/l

32.0

35.8

0.75

214

(3022621) pH of Urine by Test strip

420

2753

1.57

16.04

3.5

2.9

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

12.34

16.02

1.2

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

137

644

2.16

15.64

1.2

u/l

68.2

26.9

1.84

122

558

(3047007) Chlamydophila sp Ab [Presence] in Serum

116

515

2.28

15.24

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

557

3921

1.47

15.17

3.5

4.1

ug/l

9.2

24.0

2.54

453

3205

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

217

3.02

15.15

1.9

1.6

u/l

5.4

4.9

0.09

103

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

115

514

2.26

14.88

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

280

2.74

14.82

1.5

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

175

3.22

14.59

2.1

1.6

—

(3014271) Vancomycin [Susceptibility]

170

3.26

14.59

3.6

2.7

—

(3029937) Albumin [Presence] in Urine by Test strip

1351

11034

1.30

14.49

5.9

3.7

estimate

0.0

1.94

540

3662

(3032743) Legionella sp IgG Ab [Presence] in Serum

11.57

14.42

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.90

14.41

2.4

4.2

—

(3032057) Clostridioides difficile [Presence] in Stool

4.61

14.21

2.0

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

171

904

1.92

14.18

1.8

1.6

e6/l

20194.3

11887.8

0.70

122

648

(3036525) Urea [Moles/time] in 24 hour Urine

10.03

14.02

1.9

3.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

102

445

2.32

13.99

1.6

1.5

66.6

59.3

1.04

280

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

188

1032

1.85

13.89

2.0

1.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

4.02

13.77

1.5

2.9

2.6

0.11

(21494567) Legionella sp IgM Ab [Presence] in Serum

10.74

13.75

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

109

3.78

13.66

2.3

2.8

umol/l

25.6

28.9

1.07

(3034770) Mitochondria Ab [Titer] in Serum

194

1086

1.82

13.47

1.2

1.3

titre

345.6

1147.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

202

1145

1.79

13.45

1.4

ug/g

272.0

276.9

0.11

109

661

(3044941) Cell count panel - Synovial fluid

123

590

2.11

13.39

1.6

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

219

1275

1.75

13.31

1.3

miu/ml

208.6

217.3

0.11

581

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

6.92

13.13

6.3

2.6

mg/l

1.3

2.2

0.51

(3019150) Specific gravity of Urine by Refractometry

1131

9131

1.30

13.04

5.5

3.8

kg/l

1.0

0.45

185

1393

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

120

577

2.10

13.00

1.1

au/ml

10.0

12.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

194

1104

1.79

12.77

1.2

1.3

titre

92.9

80.7

0.23

(3014891) Appearance of Pleural fluid

6.69

12.73

2.3

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

184

1033

1.81

12.67

1.5

1.4

—

(40768795) Lymph node Pathology biopsy report

346

2.42

12.64

1.4

1.2

—

(3023410) Appearance of Cerebral spinal fluid

396

2.32

12.59

1.5

2.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

9.40

12.54

1.2

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

276

2.59

12.53

1.7

1.6

—

(3019225) pH of Specimen

552

4031

1.41

12.26

8.9

3.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

111

532

2.11

12.15

1.2

1.1

g/l

1.5

0.01

104

480

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.48

12.11

1.4

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.48

12.11

1.4

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.48

12.11

1.4

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

225

1356

1.69

12.10

1.8

1.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

147

786

1.89

11.84

1.2

—

9.1

—

(3025315) Body weight

7.41

11.83

3.5

3.3

—

(3017732) Neutrophils [#/volume] in Blood

403

2795

1.48

11.80

3.7

2.6

e9/l

4.7

4.0

4.06

305

2187

(3034426) Prothrombin time (PT)

127

3.33

11.60

1.4

1.2

—

(3047189) Immunofixation for 24 hour Urine

179

2.92

11.57

2.3

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

201

2.80

11.55

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

22.92

11.55

1.3

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

149

3.11

11.37

2.1

2.5

umol/l

138.8

164.9

0.17

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

156

863

1.83

11.31

4.5

1.8

nmol/l

1.1

0.8

4.01

136

726

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

204

2.76

11.25

1.4

1.2

—

(40768804) Tissue Pathology biopsy report

1910

16656

1.23

11.02

2.2

2.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

7.29

10.98

4.2

3.0

—

(3051611) Lipemic interference index of Serum or Plasma

370

2.26

10.92

4.0

3.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

143

780

1.86

10.86

1.3

1.2

u/ml

5.1

2.1

—

(40761535) Cells panel - Urine sediment

465

3369

1.42

10.78

5.0

3.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.30

10.75

3.3

2.7

—

(36660697) Celiac disease serology panel - Serum

463

3370

1.41

10.45

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.56

10.45

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

228

1443

1.61

10.16

1.3

1.2

u/ml

1.0

0.6

0.21

125

(3020393) Adenovirus Ag [Presence] in Stool

4.33

10.03

1.6

1.5

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

4.46

10.00

1.6

9.5

5.8

0.39

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

6.09

9.91

1.2

u/l

20.8

27.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

349

2.22

9.78

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

164

965

1.72

9.70

1.3

1.2

u/ml

21.9

3.3

0.50

(3028707) Methadone [Presence] in Urine by Screen method

141

795

1.79

9.67

3.9

3.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4319

41083

1.25

9.64

5.1

4.4

mmol/l

6.2

5.9

23.20

4012

37493

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.73

9.58

1.4

1.2

ug/l

125.3

937.2

0.98

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

278

2.35

9.46

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

278

2.35

9.46

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

279

2.35

9.39

1.2

—

(3011985) Renin [Units/volume] in Plasma

103

530

1.96

9.38

1.3

1.5

mu/l

84.7

74.6

0.13

471

(3027923) C peptide [Moles/volume] in Serum or Plasma

219

2.53

9.34

1.5

1.4

nmol/l

1.2

1.1

0.21

169

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.75

9.31

1.4

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

164

978

1.70

9.26

1.3

1.2

u/ml

5.4

7.7

0.48

150

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

281

2.33

9.24

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

686

5410

1.31

9.17

2.1

1.8

1.6

1.4

3.14

588

4808

(3004446) Plasmodium sp identified in Blood by Light microscopy

5.31

9.15

2.3

2.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

192

2.62

9.14

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

131

2.99

9.13

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

440

2.04

9.08

1.3

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

121

3.07

9.07

1.2

1.3

90.4

85.7

0.26

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

169

1023

1.67

9.03

2.8

2.4

ug/min

126.0

97.0

0.39

100

624

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

211

2.53

9.02

1.5

u/l

5.3

6.5

0.91

187

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

172

1047

1.66

9.00

1.3

1.2

u/ml

55.1

38.3

—

(3044927) Protein electrophoresis panel - Urine

375

2.12

8.98

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1283

10935

1.23

8.86

1.8

1.6

mmol/l

1.6

1.4

9.96

1125

9254

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

281

2.29

8.80

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

281

2.29

8.80

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1420

12237

1.22

8.78

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

568

4391

1.33

8.75

1.9

1.7

—

(3012565) Volume of 24 hour Urine

185

2.61

8.73

2.8

2.4

1995.6

2098.4

0.23

167

(3004716) Salmonella sp identified in Stool by Organism specific culture

306

2137

1.46

8.69

1.4

1.3

—

(3000012) Reticulocyte production index

209

2.50

8.69

2.3

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.02

8.64

2.2

3.8

—

(3011544) Albumin [Mass/volume] in Pleural fluid

6.38

8.52

1.2

g/l

16.3

16.4

0.01

(3004775) Volume in Urine collected for unspecified duration

337

2.15

8.50

2.5

2.3

693.7

630.2

0.49

228

(3000330) Specific gravity of Urine by Test strip

305

2139

1.45

8.48

4.7

3.1

—

(46236302) HLA-C [Type] by High resolution typing

8.48

8.46

1.0

—

(40763590) HLA-DQ beta [Type]

8.48

8.46

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.57

8.38

1.9

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

213

1391

1.55

8.36

3.0

3.5

u/ml

838.8

3953.5

0.83

178

1183

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

5.78

8.32

14.1

3.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

335

2.13

8.23

1.4

promille

1.4

0.04

262

(3022145) Colonoscopy Study observation

584

4582

1.31

8.09

1.4

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

101

545

1.87

8.04

1.3

nmol/l

0.6

0.05

529

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

125

2.89

7.99

1.1

89.7

86.2

0.24

(3051387) C reactive protein [Mass/volume] in Capillary blood

151

921

1.66

7.89

6.0

3.0

mg/l

34.8

25.3

2.16

108

563

(3045716) Anion gap in Serum or Plasma

166

2.60

7.83

2.7

2.4

mmol/l

8.7

9.6

0.90

130

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

122

2.88

7.73

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.14

7.66

1.3

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

181

2.50

7.55

3.4

2.0

umol/l

27.1

28.9

0.69

175

(3048879) Bone marrow aspiration report

108

2.97

7.48

2.2

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

119

2.87

7.46

1.5

1.2

—

(3049717) Cytology report of Urine Cyto stain

236

1617

1.48

7.43

2.4

2.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.61

7.39

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

13.36

7.37

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

196

2.41

7.32

1.2

nmol/l

142.9

132.5

0.77

196

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

167

2.53

7.23

1.2

1.1

u/l

32.5

22.8

0.38

123

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

168

2.51

7.15

1.2

1.1

u/l

99.4

83.8

0.41

127

(3013862) HLA-DP [Type]

7.70

7.12

1.0

—

(40760409) HLA-A [Type] by High resolution

7.70

7.12

1.0

—

(40760410) HLA-B [Type] by High resolution

7.70

7.12

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

257

2.19

7.01

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

232

2.25

6.97

2.5

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

258

2.18

6.95

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

345

2.01

6.92

1.5

1.4

22.9

29.3

0.74

217

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

253

2.19

6.86

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

2.92

6.83

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

103

2.92

6.83

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

273

2.14

6.83

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

136

841

1.63

6.79

1.4

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

547

1.79

6.77

1.3

nmol/l

0.2

0.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

249

2.18

6.70

1.1

iu/ml

20.3

11.8

—

(3002256) Pathology report gross observation

658

5366

1.26

6.68

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

256

2.16

6.67

1.3

1.2

—

(4198724)

205

2.30

6.65

2.2

3.9

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.99

6.64

1.6

1.2

26.1

37.3

0.78

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

493

1.82

6.60

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.72

6.58

2.7

4.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.57

6.58

1.3

1.2

21.3

56.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.17

6.55

1.2

92.4

74.6

—

(21494755) Public health laboratory ask at order entry panel

336

4441

0.74

6.54

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.21

6.48

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

475

1.82

6.45

1.3

nmol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.13

6.43

1.3

1.1

—

(3016750) Collection duration of Urine

242

2.16

6.33

2.7

2.2

min

491.3

497.0

0.11

189

(3045414) Leukocytes [Presence] in Urine

258

1857

1.41

6.29

2.3

1.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.46

6.28

2.7

4.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

125

773

1.63

6.27

1.3

1.2

u/ml

41.3

43.3

0.05

(1001926) Buprenorphine [Presence] in Urine by Screen method

217

1516

1.45

6.24

3.0

2.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

132

2.59

6.19

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

157

2.43

6.09

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

145

937

1.56

6.07

2.1

1.9

iu/l

3.8

4.8

0.62

331

(3016244) Insulin [Units/volume] in Serum or Plasma

273

2.06

6.07

3.6

3.1

mu/l

19.4

28.5

1.46

257

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.09

6.03

1.8

1.2

g/l

310.2

24.2

0.49

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.23

6.00

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

147

2.46

5.93

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.85

5.93

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

352

1.91

5.90

1.2

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

353

1.91

5.85

1.6

1.3

e6/l

43893.3

121572.5

1.26

254

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

505

1.75

5.85

1.3

1.4

pmol/l

300.8

312.9

0.10

382

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

287

2131

1.37

5.83

2.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.82

5.82

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.82

5.82

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.01

5.79

1.1

97.6

79.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

102

2.75

5.78

12.5

7.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

174

2.31

5.75

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

309

4053

0.75

5.72

1.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.91

5.71

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

187

1299

1.46

5.58

4.4

3.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

222

2.13

5.56

2.6

3.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.14

5.45

2.0

1.7

ng/l

87.1

146.5

1.72

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

349

1.87

5.39

1.2

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

158

1070

1.49

5.37

5.7

3.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

212

2.13

5.37

1.5

1.6

u/field

1.4

2.6

0.87

150

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

393

1.82

5.36

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

194

2708

0.71

5.35

1.5

1.4

—

(3036603) Volume of Urine

253

2.03

5.32

1.8

1.5

2061.5

1909.7

0.26

(3004616) Nuclear Ab [Presence] in Serum

461

1.75

5.28

1.3

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

283

1.95

5.19

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.88

5.18

1.0

1.3

—

(40768441) Liver Pathology biopsy report

291

1.93

5.14

1.7

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

341

1.86

5.12

2.2

1.9

u/field

4.1

1.8

0.85

125

(40768443) Skin Pathology biopsy report

242

1794

1.37

5.01

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.63

4.97

1.7

1.5

g/l

13.9

12.6

0.29

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.78

4.87

1.1

1.2

pmol/l

293.7

292.2

0.01

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

9.01

4.78

12.1

6.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

278

1.92

4.76

1.3

1.1

—

2.6

—

(3014051) Protein [Presence] in Urine by Test strip

142

969

1.48

4.70

2.7

2.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

340

2676

1.29

4.66

1.2

iu/ml

92.9

146.9

2.33

106

983

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.50

4.61

1.3

1.2

—

(40758292) HTLV I+II Ab panel - Serum

2.91

4.59

1.8

1.3

—

(3016135) IgD [Mass/volume] in Serum

10.01

4.51

1.3

1.0

mg/l

19.4

33.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

210

1551

1.37

4.49

1.7

1.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.15

4.48

1.5

1.1

mmol/l

1.1

1.7

1.74

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

201

2.05

4.47

8.2

5.8

u/ml

27.7

15944.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

142

2.26

4.46

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

113

2.40

4.30

3.2

2.0

—

(3016879) Cocaine [Presence] in Urine

239

1816

1.33

4.26

3.1

2.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

165

2.13

4.24

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

217

1629

1.35

4.20

1.5

1.4

iu/l

24.6

24.8

0.03

176

1350

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.27

4.18

2.4

4.0

—

(1761868) Lipid panel - Serum or Plasma

1401

15400

0.88

4.17

3.1

2.7

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.44

3.98

5.6

5.1

umol/l

553.7

385.8

—

(3013637) Mi-2 Ab [Presence] in Serum

2.60

3.96

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.60

3.96

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.60

3.96

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.60

3.96

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

129

897

1.45

3.94

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

177

2.04

3.93

1.5

1.3

3.3

3.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

207

1560

1.34

3.93

1.8

1.6

mu/l

349.7

285.0

1.14

189

1424

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.64

3.92

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

112

2.33

3.91

3.4

1.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

113

767

1.48

3.91

1.1

u/ml

5.2

2.1

0.62

202

(3025018) Bordetella pertussis Ab [Titer] in Serum

233

1.90

3.91

1.3

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

178

2.03

3.88

2.0

2.3

umol/l

55.9

52.9

0.13

147

(3030313) Adrenal Ab [Titer] in Serum

3.80

1.4

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

120

2.26

3.79

2.6

1.9

e6/l

9818.0

20440.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.53

3.76

2.9

1.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

140

2.15

3.76

3.2

2.1

e6/l

422.7

729.8

1.10

108

(1002224) Polysomnography panel

231

1787

1.31

3.68

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

6.67

3.67

3.4

4.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.12

3.64

1.6

1.2

mmol/l

1.4

2.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

136

2.14

3.60

1.1

1.2

4.5

31.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

118

823

1.44

3.59

1.1

u/ml

6.5

6.0

0.12

435

(3000764) Benzodiazepines [Presence] in Urine

249

1953

1.29

3.58

3.1

2.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.95

3.57

1.1

u/ml

0.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.05

3.52

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

6.16

3.50

1.1

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

257

1.80

3.49

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.34

3.47

4.3

3.1

—

(3051593) INR in Capillary blood by Coagulation assay

186

1.94

3.47

7.8

13.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

314

2544

1.25

3.46

1.2

1.3

au/ml

35.4

57.8

1.26

110

(3027944) Amphetamines [Presence] in Urine

245

1927

1.28

3.46

2.5

2.1

—

(3028300) Cannabinoids [Presence] in Urine

249

1968

1.28

3.39

3.1

2.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.39

3.38

1.2

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

128

917

1.41

3.38

1.2

1.1

u/ml

1.5

1.8

0.20

389

(3027008) Opiates [Presence] in Urine

248

1961

1.28

3.37

3.1

2.0

—

(3007463) Buprenorphine [Presence] in Urine

5.01

3.36

8.7

6.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

114

2.20

3.34

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.25

3.34

1.0

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

189

1.91

3.33

1.2

1.1

u/ml

82.6

6.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.36

3.31

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.92

3.29

1.1

1.0

—

(3020491) Glucose [Moles/volume] in Blood

315

1.69

3.27

1.6

1.9

mmol/l

7.9

6.4

1.23

222

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

8.58

3.26

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

113

798

1.42

3.25

1.1

u/ml

1.2

1.1

0.06

361

(3024263) Appearance of Synovial fluid

191

1.89

3.23

1.6

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.34

3.19

2.5

2.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.34

3.19

2.0

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

185

1.90

3.18

2.1

2.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.08

1.1

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.80

3.08

1.1

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

100

698

1.44

3.08

1.2

1.1

iu/ml

14.5

860.9

0.58

165

(3035320) C reactive protein [Mass/volume] in Body fluid

292

1.68

3.02

3.2

2.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

175

1.89

2.99

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.29

2.99

7.3

1.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

686

1.44

2.98

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.35

2.98

1.5

1.4

u/ml

0.1

6.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

220

1.78

2.92

3.8

2.8

umol/l

45.0

43.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

592

1.46

2.87

1.1

u/ml

10.0

4.3

0.91

253

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

5.39

2.87

8.3

11.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.39

2.87

2.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

136

1.99

2.84

2.9

2.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

206

1631

1.27

2.82

2.7

2.3

u/l

4459.5

6185.7

0.40

634

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.23

2.79

14.2

8.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

111

807

1.38

2.76

1.5

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

181

1.83

2.72

1.1

miu/ml

1575.0

1551.7

0.04

181

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

233

1.72

2.71

1.3

1.1

ratio

1.2

1.0

1.28

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.24

2.70

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

559

1.46

2.69

3.0

2.5

umol/l

6.0

8.2

0.76

413

(4212803)

2.98

2.69

1.2

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

234

1.71

2.67

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

334

2805

1.20

2.67

2.3

2.4

au/ml

35.5

24.1

0.68

160

(3029075) Extractable nuclear Ab panel - Serum

112

2.06

2.66

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

351

2964

1.20

2.65

2.2

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

321

2691

1.20

2.62

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.66

2.62

1.1

1.2

—

(3000285) Sodium [Moles/volume] in Blood

2.46

2.61

1.3

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

4.67

2.59

1.0

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

200

1.75

2.55

1.1

1.3

u/l

230.1

351.9

0.59

185

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.73

2.54

1.7

2.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.60

2.53

1.6

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.60

2.53

1.1

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.81

2.46

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4390

42977

1.11

2.45

5.2

4.7

mmol/l

2.6

2.7

20.67

4076

39723

(44806071)

2.67

2.45

1.2

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.55

2.44

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

257

1.64

2.41

1.6

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

2.26

2.34

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

214

1.69

2.31

1.3

55.2

66.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

167

1325

1.27

2.31

1.6

1.5

u/l

9.2

8.5

0.31

131

1057

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.31

2.0

1.9

mmol/l

1.3

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.86

2.30

1.3

1.1

—

(3045424) Erythrocytes [Presence] in Urine

671

1.38

2.30

1.6

1.5

—

(40765096) Chromosome analysis panel by Banding

119

1.94

2.30

1.0

1.2

—

(40768800) Prostate Pathology biopsy report

978

0.70

2.27

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.56

2.27

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.48

2.27

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.28

2.24

14.2

8.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4140

40474

1.10

2.20

4.4

3.8

mmol/l

1.4

1.3

25.16

3844

37202

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

288

1.57

2.18

1.3

1.5

u/ml

20.9

21.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

4.29

2.15

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.69

2.15

2.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

2.17

2.14

2.4

3.4

u/l

40.2

155.4

—

(3035933) Granulocytes/100 leukocytes in Blood

130

1.85

2.12

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

503

4459

1.14

2.10

1.5

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.50

2.05

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

191

0.42

2.04

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

435

3826

1.15

2.04

2.6

2.2

nmol/l

11.6

12.9

2.67

381

3394

(3039443) Prostate specific Ag panel - Serum or Plasma

922

0.71

2.03

1.5

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.40

2.02

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

932

0.72

2.02

2.0

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

475

1.42

2.01

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

597

5367

1.13

2.00

2.3

2.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

233

1.59

1.95

1.4

titre

66.0

66.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.36

1.94

1.7

2.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.55

1.94

1.4

1.3

nmol/l

804.5

497.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

4.55

1.94

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.75

1.93

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

278

2374

1.18

1.93

2.1

1.9

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

142

1.76

1.92

1.1

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

633

1.35

1.92

1.1

u/ml

6.3

4.0

0.54

263

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.18

1.88

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

3.18

1.88

1.0

u/ml

0.2

0.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

236

1.57

1.86

1.0

—

(4027681)

269

1.53

1.83

1.2

1.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.50

1.83

5.7

11.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

263

0.49

1.82

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1165

0.76

1.82

1.4

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.17

1.82

1.0

1.1

nmol/l

265.9

199.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

240

1.55

1.75

4.9

6.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.92

1.72

1.4

1.5

umol/24h

409.6

330.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

539

4870

1.12

1.69

2.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

374

1.42

1.68

1.3

1.4

mmol/l

12.0

11.8

0.06

(4034850)

108

1361

0.79

1.67

23.2

9.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.18

1.67

1.7

1.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.16

1.66

1.7

1.5

nmol/l

20.0

14.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.16

1.66

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

180

1.61

1.66

1.1

105.2

92.0

0.98

142

(3000034) Microalbumin [Mass/volume] in Urine

367

1.42

1.65

2.7

3.0

mg/l

13.0

32.6

1.80

278

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.25

1.63

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.57

1.61

6.0

6.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.00

1.59

1.1

1.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.00

1.58

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.69

1.58

1.0

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.82

1.57

1.3

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.43

1.53

1.0

—

(3025130) Human papilloma virus identified in Specimen

450

1.36

1.52

2.2

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

537

1.33

1.51

1.4

1.3

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.86

1.50

1.0

18.5

22.4

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.86

1.50

1.0

36.6

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.86

1.50

1.0

7.3

8.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

140

1153

1.22

1.50

1.1

u/ml

16.1

6.4

0.70

151

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

375

1.39

1.49

3.9

4.9

u/ml

222.2

64.3

0.57

108

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.50

1.45

1.0

1.1

u/l

3.0

9.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

353

1.39

1.43

1.1

mg/l

43.5

41.7

0.15

286

(3006270) Folate [Moles/volume] in Blood

353

1.39

1.43

1.1

nmol/l

348.9

360.4

0.14

302

(3028717) Thiamine [Mass/volume] in Blood

2.31

1.43

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

196

1.53

1.42

2.0

2.1

ug/min

112.6

205.7

—

(3002619) Bacteria identified in Specimen by Culture

1.82

1.41

1.5

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

118

1.70

1.41

1.1

1.3

nmol/l

239.8

135.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

816

0.76

1.39

1.4

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.20

1.36

1.4

1.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.61

1.36

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

151

1.59

1.34

1.1

—

(3042517) Benzodiazepines panel - Urine

2.14

1.33

2.2

2.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.13

1.33

1.0

—

(40768793) Breast Pathology biopsy report

776

0.76

1.33

1.2

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.74

1.30

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.79

1.27

1.7

1.5

ug/l

0.3

0.4

—

(3019174) dRVVT (LA screen)

2.29

1.26

1.4

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

108

1.67

1.22

2.4

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1064

0.81

1.21

1.5

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

339

1.36

1.21

1.1

mg/l

286.4

274.6

0.15

290

(3051101) Glucose [Moles/volume] in Cord blood

1.83

1.19

2.8

7.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.31

1.18

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

2.31

1.18

1.2

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.50

1.15

14.4

7.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

536

1.27

1.14

1.1

u/ml

0.7

0.3

0.32

135

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

492

1.28

1.13

2.8

2.0

mg/l

33.9

25.1

0.40

116

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.33

1.12

1.1

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.33

1.12

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4284

42264

1.06

1.12

4.7

4.2

mmol/l

4.4

4.6

23.68

3984

39296

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.96

1.11

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.78

1.10

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

176

1.48

1.10

1.0

1.1

u/ml

5.4

7.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

260

1.39

1.09

1.0

ng/l

809.7

734.7

0.42

175

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

261

1.38

1.07

1.0

ng/l

233.9

318.4

2.11

179

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

262

1.38

1.05

1.0

ng/l

28.3

44.5

3.50

177

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

324

1.33

1.02

1.6

1.4

g/l

0.9

0.08

324

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1632

15731

1.05

1.02

4.4

4.9

ug/l

2.6

3.4

0.68

1458

14175

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

333

1.32

1.01

1.1

mg/l

317.4

287.4

0.66

300

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.69

1.01

1.9

1.2

—

(3001729) Color of Synovial fluid

2.00

1.00

2.1

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.17

0.98

1.0

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.69

0.95

1.2

1.1

umol/24h

0.6

0.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.78

0.94

1.1

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

268

1.35

0.94

1.1

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.73

0.92

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

201

1.40

0.91

2.1

3.6

—

(44813793)

270

1.34

0.90

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.07

0.89

1.0

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.91

0.88

1.4

1.0

u/ml

5.2

9.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

276

0.69

0.86

1.6

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

325

1.29

0.86

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.82

0.85

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.82

0.85

1.5

2.3

u/field

0.4

0.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

1.67

0.85

2.8

2.6

u/l

1746.7

719.7

0.53

(3047352) Trisomy 18 risk [Likelihood] in Fetus

100

853

1.18

0.84

1.4

1.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.94

0.84

2.3

1.6

0.8

0.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.94

0.84

1.8

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

587

1.21

0.84

1.1

u/ml

3.2

2.9

0.11

283

(4146454)

452

1.24

0.83

3.4

2.7

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.74

0.82

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

839

1.17

0.80

2.1

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

114

1.49

0.79

1.1

1.2

g/l

34.9

40.3

0.86

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.56

0.78

1.4

2.9

ng/l

130.0

112.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

107

1.50

0.76

2.8

2.9

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

122

1069

1.14

0.75

1.9

pmol/l

182.4

207.4

1.78

115

1017

(3043238) Trisomy 21 risk [Likelihood] in Fetus

101

874

1.16

0.74

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

480

5105

0.93

0.74

4.9

4.4

32.5

32.1

0.29

352

3461

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

253

2317

1.10

0.73

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

134

1.42

0.71

2.9

2.3

mg/l

9.4

9.6

0.03

111

(3005033) Fetal Nuchal fold Thickness US

850

1.16

0.70

1.4

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

247

1.30

0.70

1.1

u/ml

1.7

2.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4236

41939

1.05

0.70

4.7

4.2

mmol/l

1.4

31.54

3930

38797

(4211845)

221

1.31

0.69

2.1

3.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.63

0.66

1.3

1.1

umol/24h

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

285

1.26

0.66

1.2

1.1

u/ml

0.5

2.3

1.46

108

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

162

1.36

0.66

3.3

3.7

mg/l

8.2

8.3

0.04

133

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

809

1.15

0.66

3.0

3.5

u/ml

123.5

721.4

1.14

742

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

167

0.66

0.65

4.2

6.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

167

0.66

0.65

2.1

3.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

883

9187

0.95

0.65

2.7

3.0

ug/l

0.7

0.8

1.18

608

5987

(4281824)

368

1.22

0.63

1.4

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

595

0.84

0.58

1.4

1.3

mmol/l

6.8

7.2

0.69

426

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.58

0.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.51

0.58

4.1

6.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

493

1.18

0.57

1.2

1.4

u/l

27.7

23.0

0.51

411

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

115

1.39

0.56

1.1

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.62

0.55

1.0

g/l

158.2

162.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

523

1.17

0.55

1.9

1.6

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.58

0.54

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.46

0.54

1.9

2.1

umol/l

13.3

16.1

0.42

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.48

0.53

1.1

u/ml

0.4

6.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.50

0.51

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

180

1661

1.09

0.50

2.2

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

491

4693

1.05

0.48

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

108

1193

0.90

0.47

1.6

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.47

0.47

1.4

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

200

1.25

0.46

1.6

1.9

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

116

1054

1.10

0.46

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

791

0.88

0.45

1.5

pmol/l

172.1

179.3

0.05

773

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

229

1.22

0.43

2.5

1.8

—

(4024509)

393

0.84

0.42

1.8

1.6

—

(3022689) Creatine [Moles/volume] in Urine

113

1.33

0.42

1.6

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

115

1051

1.10

0.42

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

231

1.21

0.41

1.0

1.1

u/l

0.9

1.1

2.25

116

(44806420)

114

1.32

0.40

2.9

2.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

115

1054

1.09

0.40

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.43

0.39

1.0

1.1

—

(4094501)

107

1166

0.92

0.38

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.30

0.37

1.0

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

124

1147

1.08

0.36

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

552

5709

0.96

0.36

1.5

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

235

1.19

0.36

1.0

1.1

nmol/l

2.9

8.8

—

(3017509) Phencyclidine [Presence] in Urine

1.43

0.35

2.0

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

114

1053

1.08

0.35

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.32

0.33

1.5

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

110

1.27

0.31

1.2

1.4

ug/l

7.5

8.9

0.89

110

(3032868) Hemoglobin electrophoresis panel in Blood

1.35

0.31

1.7

1.6

—

(3008898) HLA-B27 [Presence]

150

1413

1.06

0.29

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.29

2.1

2.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

185

1.19

0.29

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

143

1347

1.06

0.28

1.3

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

279

1.15

0.28

1.2

1.1

u/ml

7.4

2.9

0.53

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

344

0.87

0.28

1.7

1.6

mmol/l

7.5

7.8

0.35

205

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.28

0.28

3.3

2.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

153

1611

0.95

0.25

1.5

1.7

mg/l

6.1

3.5

1.14

114

1113

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

518

5313

0.97

0.24

13.8

6.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.28

0.23

1.2

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

486

1.09

0.22

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

180

1723

1.05

0.22

4.0

3.2

u/ml

35.7

56.1

1.47

170

1665

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

430

0.91

0.21

1.2

1.4

pmol/l

80.7

143.3

0.37

121

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

460

1.09

0.20

3.3

3.2

nmol/l

4.5

17.6

0.56

449

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

201

2085

0.96

0.19

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

519

0.92

0.18

1.4

1.6

—

(3015183) Erythrocyte sedimentation rate

232

1.12

0.18

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

174

0.86

0.17

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.21

0.17

1.3

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.72

0.16

1.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

121

1.16

0.15

2.0

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

202

0.89

0.14

1.0

1.3

—

(4133840)

132

1.14

0.13

1.3

1.1

—

(3020650) Glucose [Presence] in Urine

115

1.13

0.10

1.5

—

(4038314)

1.09

0.09

1.2

1.3

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

1.08

0.08

1.3

1.0

kpa

5.0

3.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1261

12682

0.99

0.08

4.0

4.3

22.4

22.0

0.34

555

6114

(3006598) pH of Arterial cord blood

1.04

0.08

1.3

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

1.04

0.08

1.3

1.0

kpa

7.3

7.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.89

0.06

1.0

mu/l

8.9

8.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

110

1.09

0.05

1.3

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

209

2106

0.99

0.03

1.6

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

550

0.98

0.02

2.5

2.3

13.5

13.1

2.36

545

(3037556) Urate [Mass/volume] in Serum or Plasma

122

0.98

0.00

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

525

0.99

0.00

1.4

ug/l

3.4

4.1

0.35

474

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

585

1.01

0.00

1.5

nmol/l

0.3

0.4

0.92

478

(3036071) Salmonella sp Ab [Titer] in Serum

131

0.99

0.00

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

20.8

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

240

1.00

0.00

1.2

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

121.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_VIRALPNEUMO and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_VIRALPNEUMO	2.106 [1.81, 2.45]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.374

During the follow-up period (1.1.1998 — 31.12.2019), 3232 out of 13001 females with J10_VIRALPNEUMO died.

Males

Parameter	HR [95% CI]	p-value
J10_VIRALPNEUMO	2.569 [2.15, 3.07]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.026

During the follow-up period (1.1.1998 — 31.12.2019), 3434 out of 14173 males with J10_VIRALPNEUMO died.

Mortality risk

Mortality risk for people of age

years, who have J10_VIRALPNEUMO.

N-year risk	Females	Males
1	0.231%	0.533%
5	1.239%	3.194%
10	3.122%	8.332%
15	6.231%	15.11%
20	10.83%	24.933%

Relationships between endpoints

↥

Index endpoint: J10_VIRALPNEUMO – Viral pneumonia

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Viral pneumonia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints